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Abstract
Many pharmaceutical manufacturing processes are costly, time-intensive, and energy-intensive. Due to the
high operational costs, optimization of these processes would result in large economic savings. Fluid bed
granulation takes inputs of air temperature, air flow rate, phase duration, binder spray rate, and inlet air
humidity. A series of simulations were run to determine optimal operating conditions. It was determined that
the process parameters should be limited to the following to meet product standards and reduce costs: air flow
rate of 2800 (m3/h), inlet air temperature of 55˚C for spraying and 75˚C for drying, phase duration 124
minutes , binder spray rate of 900 g/s, and inlet air humidity can range from 1-20 g water/kg air. The
lyophilization simulation takes process inputs of maximum process time, temperature, pressure, and vial type
and returns outputs of peak product temperature, drying time, and maximum sublimation rate. Several
primary drying simulations were run for an 8R vial dose and a 20 mL vial dose to determine the optimal
operating conditions. The conditions that resulted in the greatest operational cost savings for both the 8R vial
and the 20 mL vial were a pressure of 30 Pa, an initial temperature of -9˚C and a final temperature of 1˚C.
Based on the proposed conditions, both operational cost and equipment depreciation savings were identified
mainly due to lower run times across both processes. For fluid bed granulation, $31,136 operational annual
savings were identified amounting to $467,000 over the 15-year project. For lyophilization, $23,500 in annual
operational cost savings amounting to $352,000 over the 15-year project life were found. Further operational
savings only yielded marginal improvements in profitability.
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University of Pennsylvania, School of Engineering and Applied Science 
Department of Chemical and Biomolecular Engineering  
220 South 33rd Street Philadelphia, PA 19104  
 
April 23, 2019  
 
Dear Dr. Amish Patel and Mr. Bruce Vrana: 
 
Enclosed is a proposal for the optimization of the operating conditions of two pharmaceutical 
manufacturing processes: fluid bed granulation and lyophilization. Both of these processes were 
simulated using a “black-box” mathematical model run on MATLAB software. Each process took 
several different inputs and provided outputs to help determine how to best optimize each process. 
The project proposal specified a yearly output of 4,000,000 doses of the fluid bed granulation 
product, Botilioxin. For lyophilization, 10,000,000 8R vials and 200,000 20 mL vials of the product, 
HAJVANOX, per year are required.  
 
Fluid bed granulation is a process that is used to improve the quality of a powdered drug product. 
In this process, a binder is sprayed over the product in order to improve physical properties such as 
compressibility and flowability, as well as increase particle size. For the simulation model, the 
required inputs were air flow rate, air temperature, air humidity, binder spray rate, and phase 
duration. Lyophilization is a freeze-drying process for biologic drugs. This project focuses only on 
the primary drying step of lyophilization during which ice is sublimated out of the product vials. 
The lyophilization simulation takes inputs of chamber temperature, chamber pressure, vial type, 
process time and vial location.  
 
After running numerous simulations, we have determined improved operating conditions for both 
processes. We recommend that fluid bed granulation be run at inlet air temperatures of 55˚C for 
spraying, 75˚C for drying, an air flow rate of 2800 (m3/hr), an air humidity range of 1-20 (g 
water/kg air), a binder spray rate of 900 (g/s), and a process end time of 124 minutes. These 
conditions result in annual operational savings of $31,100 for the fluid bed products. For 
lyophilization, we recommend that it be run at an initial chamber temperature of -9C with a final 
chamber temperature of 1C at a chamber pressure of 30 Pa. This would result in annual 
operational cost savings of $23,500 for the lyophilized products. Due mainly to a reduction of 
process run times, additional savings were identified for equipment depreciation over the project 
lifetime. An NPV sensitivity analysis also indicated that further cost savings would have minimal 
positive impact on the recommended cases. 
 
Sincerely, 
 
 
________________________             ______________________             ______________________ 
                             Emily Cunningham                 Rachel Wilson                         Marc Geagea 
 
 2 
Future API Manufacturing 
Excellence 
 
 
Emily Cunningham 
Rachel Wilson 
Marc Geagea 
 
 
 
Project Author: Dr. Alex Marchut 
Project Advisor: Dr. Amish Patel 
 
 
 
 
University of Pennsylvania  
School of Engineering and Applied Science 
Department of Chemical and Biomolecular Engineering  
April 23, 2019 
 
 
 
 
 3 
Table of Contents 
 
Section               Page 
1 - Abstract .................................................................................................................................................................................. 8 
2 - Introduction and Objective Time Chart ................................................................................................................. 10 
 2.1 – Introduction .................................................................................................................................................. 11 
2.1.1 – Fluid Bed Granulation ............................................................................................................ 11 
2.1.2 – Lyophilization ........................................................................................................................... 14 
                2.1.3 – Economic Analysis .................................................................................................................. 16 
 2.1 – Project Charter ............................................................................................................................................. 17 
3 – Innovation Map ............................................................................................................................................................... 19 
4 – Market and Competitive Analysis ............................................................................................................................ 20 
5 – Customer Requirements .............................................................................................................................................. 21 
6 – Critical-to-Quality Variables ...................................................................................................................................... 22 
7 – Product Concept.............................................................................................................................................................. 23 
8 – Superior Product Concept .......................................................................................................................................... 24 
9 – Competitive Patent Analysis ...................................................................................................................................... 25 
10 – Preliminary Process Synthesis ............................................................................................................................... 26 
11 – Assembly of Database ................................................................................................................................................ 27 
12 – Process Flow Diagrams and Material Balances ............................................................................................... 28 
13 – Process Description .................................................................................................................................................... 33 
 13.1 – Fluid Bed Granulation Simulation Description ............................................................................ 34 
 13.2 – Fluid Bed Granulation Equipment Flowsheet Description ..................................................... 35 
 13.3 – Fluid Bed Granulation Optimization Approach ........................................................................... 37 
 13.4 – Lyophilization Simulation Description ........................................................................................... 40 
 13.5 – Lyophilization Equipment Flowsheet Description ..................................................................... 43 
 13.6 – Lyophilization Optimization Approach ........................................................................................... 44 
14 – Energy Balance and Utility Requirements ........................................................................................................ 48 
 14.1 – Fluid Bed Granulation Utility Requirements ................................................................................ 49 
 14.2 – Lyophilization Utility Requirements ................................................................................................ 50 
15 – Equipment List and Unit Descriptions ................................................................................................................ 54 
 4 
 15.1 – Fluid Bed Granulation Equipment..................................................................................................... 55 
 15.2 – Lyophilization Equipment .................................................................................................................... 61 
16 – Specification Sheets .................................................................................................................................................... 75 
 16.1 – Fluid Bed Granulation Specification Sheets .................................................................................. 76 
 16.2 – Lyophilization Specification Sheets .................................................................................................. 83 
17 – Equipment Cost Summary ....................................................................................................................................... 93 
 17.1 – Fluid Bed Granulation Equipment Cost Summary...................................................................... 94 
 17.2 – Lyophilization Equipment Cost Summary ..................................................................................... 95 
18 – Scheduling ...................................................................................................................................................................... 96 
19 – Fixed-Capital Investment Summary .................................................................................................................... 97 
20 – Operating Cost .............................................................................................................................................................. 98 
 20.1 – General Methodology.............................................................................................................................. 99 
 20.2 – Fluid Bed Granulation Methodology ................................................................................................ 99 
 20.3 – Lyophilization Methodology ............................................................................................................. 103 
 20.4 – Main Cost Drivers .................................................................................................................................. 106 
20.4.1 – Fluid Bed Granulation ...................................................................................................... 108 
20.4.2 – Lyophilization ..................................................................................................................... 109 
21 – Profitability Analysis ............................................................................................................................................... 110 
 21.1 – Analysis of Fluid Bed Granulation Profitability ........................................................................ 111 
 21.2 – Analysis of Lyophilization Profitability ........................................................................................ 115 
 21.3 – Profitability Caveats ............................................................................................................................. 119 
22 – Additional Considerations .................................................................................................................................... 120 
 22.1 – Environmental Considerations ........................................................................................................ 121 
 22.2 – Good Manufacturing Practices ......................................................................................................... 122 
 22.3 – Federal Drug Administration Regulations .................................................................................. 124 
23 – Conclusions and Recommendations ................................................................................................................. 126 
24 – Acknowledgements .................................................................................................................................................. 129 
25 – References ................................................................................................................................................................... 131 
26 – Appendix ...................................................................................................................................................................... 135 
 26.1 – Project Statement .................................................................................................................................. 136 
 26.2 – Code Snippets ......................................................................................................................................... 137 
 5 
 26.3 – Equipment Design Calculations....................................................................................................... 142 
26.3.1 – Fluid Bed Granulation Equipment Design Calculations ..................................... 142 
26.3.2 – Lyophilization Equipment Design Calculations .................................................... 149 
 26.4 – Fluid Bed Granulation Simulation Results .................................................................................. 163 
 26.5 – Lyophilization Simulation Results ................................................................................................. 171 
 26.6 – Economic Cost Summaries ................................................................................................................ 185 
 26.7 – Financial Summary of NPV Analysis ............................................................................................. 191 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
Tables                   Page 
13.1.1 – Fluid Bed Granulation Process Parameters ............................................................................................... 35 
13.3.1 – Fluid Bed Granulation Process Constraints ............................................................................................... 37 
14.1.1 – Fluid Bed Granulation Base Case Utility Requirements per Batch .................................................. 49 
14.1.2 – Fluid Bed Granulation Case Utility Requirements per Batch ............................................................. 50 
14.2.1 – Lyophilization 8R Base Case Utility Requirements per Batch ........................................................... 51 
14.2.2 – Lyophilization 8R Recommended Case Utility Requirements per Batch ...................................... 52 
14.2.3 – Lyophilization 20ml Base Case Utility Requirements per Batch ...................................................... 52 
14.2.4 – Lyophilization 20ml Recommended Case Utility Requirements per Batch ................................. 53 
17.1.1 – Fluid Bed Granulation Equipment Costs..................................................................................................... 94 
17.2.1 – Bare Module Cost of Vacuum Pumps ........................................................................................................... 95 
20.4.1 – Summary of Annual Operational Costs .................................................................................................... 107 
21.1.1 – Fluid Bed Granulation Operational Cost Savings ................................................................................. 111 
21.1.2 – Fluid Bed Granulation Depreciation Savings ......................................................................................... 112 
21.1.3 – Fluid Bed Granulation NPV Sensitivity ..................................................................................................... 115 
21.2.1 – Lyophilization Proposed Conditions ......................................................................................................... 115 
21.2.2 – Lyophilization Operational Cost Savings ................................................................................................. 116 
21.2.3 – Lyophilization Depreciation Savings ......................................................................................................... 117 
21.2.4 – Lyophilization NPV Sensitivity .................................................................................................................... 119 
23.1.1 – Fluid Bed Granulation Proposed Conditions ......................................................................................... 127 
 
 
 
 
 
 7 
Figures              Page 
12.1 – Fluid Bed Granulation Input/Outputs ............................................................................................................. 29 
12.2 – Fluid Bed Granulation Process Flowsheet ..................................................................................................... 30 
12.3 – Lyophilization Input/Outputs............................................................................................................................. 31 
12.4 – Lyophilization Process Flowsheet .................................................................................................................... 32 
13.1.1 – Fluid Bed Granulation Input Profile ............................................................................................................. 34 
13.3.1 – Fluid Bed Granulation Design Space ............................................................................................................ 38 
13.4.1 – Lyophilization Input Profile ............................................................................................................................. 40 
13.6.1 – Lyophilization 8R Design Space ..................................................................................................................... 45 
13.6.2 – Lyophilization 20ml Design Space ................................................................................................................ 46 
20.2.1 – Fluid Bed Granulation Base Case Operational Cost Summary ........................................................ 100 
20.2.2 – Fluid Bed Granulation Base Case Labor Summary .............................................................................. 101 
20.2.3 – Fluid Bed Granulation Base Case Utility Summary ............................................................................. 102 
20.3.1 – Lyophilization Base Case Operational Cost Summary ....................................................................... 104 
20.3.2 – Lyophilization Base Case Labor Summary .............................................................................................. 105 
20.3.3 – Lyophilization Base Case Utility Summary ............................................................................................. 106 
20.4.1 – Fluid Bed Granulation Cost Components ................................................................................................ 108 
20.4.2 – Lyophilization Cost Components ................................................................................................................ 109 
21.1.1 – Fluid Bed Granulation NPV Summary ....................................................................................................... 114 
21.2.1 – Lyophilization NPV Summary ...................................................................................................................... 118 
 
 
 
 
 8 
 
 
 
Section 1: Abstract 
 
 
 
 
 
 
 
 9 
Many pharmaceutical manufacturing processes are costly, time-intensive, and 
energy-intensive. Due to the high operational costs, optimization of these processes would 
result in large economic savings. Fluid bed granulation takes inputs of air temperature, air 
flow rate, phase duration, binder spray rate, and inlet air humidity. A series of simulations 
were run to determine optimal operating conditions. It was determined that the process 
parameters should be limited to the following to meet product standards and reduce costs: 
air flow rate of 2800 (m3/h), inlet air temperature of 55˚C for spraying and 75˚C for drying, 
phase duration 124 minutes , binder spray rate of 900 g/s, and inlet air humidity can range 
from 1-20 
𝑔 𝑤𝑎𝑡𝑒𝑟
𝑘𝑔 𝑎𝑖𝑟
. The lyophilization simulation takes process inputs of maximum process 
time, temperature, pressure, and vial type and returns outputs of peak product 
temperature, drying time, and maximum sublimation rate. Several primary drying 
simulations were run for an 8R vial dose and a 20 mL vial dose to determine the optimal 
operating conditions. The conditions that resulted in the greatest operational cost savings 
for both the 8R vial and the 20 mL vial were a pressure of 30 Pa, an initial temperature of -
9˚C and a final temperature of 1˚C. Based on the proposed conditions, both operational cost 
and equipment depreciation savings were identified mainly due to lower run times across 
both processes. For fluid bed granulation, $31,136 operational annual savings were 
identified amounting to $467,000 over the 15-year project. For lyophilization, $23,500 in 
annual operational cost savings amounting to $352,000 over the 15-year project life were 
found. Further operational savings only yielded marginal improvements in profitability.  
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Section 2.1 Introduction 
We are members of a strategy group in a large pharmaceutical company that focuses 
on developing business cases for potential high-impact technologies. For our report, we 
have been given access to mathematical models that simulate two pharmaceutical 
manufacturing processes: fluid bed granulation and lyophilization. We are interested in 
using these models to optimize these processes for two different products. 
 Botilioxin is a small molecule drug manufactured in China and sold in the EU 
market. It is a high-volume generic drug that is off-patent, but still a well-recognized brand 
name. Botilioxin is a tablet that is taken orally and undergoes the process of fluid bed 
granulation during manufacturing. 
 HAJVANOX is a new large molecule drug that is manufactured in Switzerland and 
mainly sold to the EU market. HAJVANOX is currently patented and by nature of being a 
biologic, it is unlikely to experience significant competition even when it goes off-patent. It 
is a freeze-dried antibody that is administered to the patient via intravenous injection, 
typically in a hospital setting. HAJVANOX is a lower volume product that goes through the 
process of lyophilization or freeze drying. 
Section 2.1.1 Fluid Bed Granulation 
 Fluid bed granulation (FBG) is a process in which powder granules are treated with 
binders in order to increase the quality of the product downstream. The advantages of this 
process are that it creates an environment for high rates of heat and mass transfer, leading 
to uniform temperature distribution and shorter processing times (Ennis, Tardos, & 
Turton, 1998). This process allows for the product to achieve more desirable properties 
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like improved flowability, appearance, reduction of dust, and compressibility. The main 
steps of focus in the fluid bed granulation process are coating and drying.  
 During the coating process, a liquid binder is pumped into a bed of powdered 
product. The product is contained in a mixer, which provides shearing forces within the 
powdered mass. While the binder solution evaporates, the particles of product agglomerate 
together, forming larger particle sizes. This is caused by the interparticle bridges and 
capillary regions strengthening resulting in increased particle size. A gas, typically purified 
air, is used to change temperature of the product during different phases. While this type of 
granulation possesses many complexities, it provides the ability to both heat and cool the 
product at the same time (Ennis et. al., 1998). For this process, all operations occur at 
atmospheric pressure.  
 During the coating step of the operation, the powdered product is sprayed with a 
binder solution that allows the particles to agglomerate together and form even larger 
particles. When the liquid is sprayed onto the particles, the liquid distributes itself amongst 
the powder and creates liquid bridges amongst them. As the process continues, more liquid 
bridges are formed between particles which alters the bulk properties of the product. This 
action is continued until the desired particle size is reached. To determine this, the critical 
binder liquid to powder ratio must be calculated through experimental methods. While the 
powder is agitated, the binder is slowly added in order to easily track the differences in 
binder concentration (Ennis et. al., 1998). The torque of the pump and the electric power 
required are monitored. This produces a plot of torque versus the amount of liquid added 
to the powder. Based on this information, the critical ratio can be determined for any 
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product. In this project, the assumption has been made that the required ratios for this 
product have been accounted for in the simulation.  
While the binder is being pumped over the agitated bed, purified air is blown 
through the process as well. The purpose of the air is to control the heat and mass transfer 
of the process. During this phase, the air temperature is maintained between 46˚C and 55˚C, 
which have been determined to be the optimal temperatures for the process. The 
temperature of the air is controlled by a countercurrent heat exchanger.  
The final step in the fluid bed granulation process is drying. During this step, the air 
temperature is increased to a critical temperature that will dry the product to a specified 
loss of drying percentage (LOD%). For this application, the optimal air temperature for 
drying falls between 70˚C and 75˚C. Loss of drying percentage is defined as the moisture 
content that the powder reaches during operation. The values of concern in this application 
are the End LOD% and Max LOD% values. End LOD% is the moisture content of the 
product at the end of the operation and Max LOD% is the maximum moisture that the 
product reaches during operation. It is preferred the product reaches its Max LOD% at the 
end of the operation. After the drying step is completed, the product is moved downstream 
to the rest of production.  
 The main objective for fluid bed granulation in this project is to achieve a more 
efficient process which lowers utility costs and produces product that falls within quality 
standards.  
 
 
 14 
Section 2.1.2 Lyophilization 
Lyophilization is a freeze-drying process in which ice is sublimed out of the product 
vial. This process is typically performed on large molecule drugs because traditional 
heating methods would likely destroy the physical structure of the protein. These products 
are unstable in the frozen or liquid form, thus freeze drying allows easier storage and 
transportation while extending shelf life. Solutions for freeze drying contain 80-95% water 
with the active pharmaceutical ingredient along with additives such as buffers, bulking 
agents, and stabilizers (Ward, 2019). Not only does lyophilization provide advantages in 
storage and transportation but it also allows for modification of the formulation after 
manufacturing and prior to administration (Varshney, 2016).  
Lyophilization consists of three main steps: freezing, primary drying, and secondary 
drying. During freezing, the lyophilization chamber is set at a very low temperature, 
approximately 10-20˚C below the product’s freezing point, so that ice nucleation and 
crystallization of water occur. The solute will concentrate between ice crystals until it 
either crystallizes or forms an amorphous glass (Mortier, 2016). Annealing is an optional 
step that may be performed after drying to optimize the ice crystal size and increase the 
rate of primary drying. During primary drying, the frozen ice in the vial is sublimated by 
setting the chamber to a very low pressure while slowly increasing temperature from the 
freezing temperature to provide heat for sublimation. Secondary drying is carried out at a 
higher temperature so that any leftover water molecules will evaporate. The product 
temperature will be approximately the same as the shelf temperature throughout 
 15 
secondary drying and pressure is not an important variable. Once the drying chamber is 
free of water vapor, the secondary drying step is complete (Bockstal, 2017). 
The process of lyophilization, and primary drying in particular, is extremely time 
and energy intensive. Lyophilization is typically run at suboptimal conditions because there 
is often low active pharmaceutical ingredient (API) availability during early process 
development, making it difficult to run sufficient experiments to determine optimal 
operating conditions. Primary drying is the longest and often most important phase. Since 
optimization of primary drying will result in the greatest decrease in process times, this 
project will focus only on the primary drying step.  
In primary drying, once the ice is sublimated, the water vapor is then drawn into the 
condenser where it is cooled back into ice. It is assumed that pure water is being 
sublimated out of the product, although in reality this solution may contain excipients, 
solvents, and other fillers. The majority of the vapor will be comprised of water, so the ice 
and vapor are assumed to have the properties of pure water. Each product has a specific 
collapse temperature above which there is loss of physical structure of the dried product 
cake (Ward, 2019). The product within the chamber must never reach this temperature. 
Product temperature is a function of heat and mass transfer, both of which depend on the 
physical properties of the product, vial volume and design, shelf temperature, chamber 
pressure, and condenser and vacuum pump capacity. The vials at the corners and edges of 
the oven receive more heat via radiation so these vials often dry faster than the center 
vials, making them the limiting factor in energy transfer due to increased risk of cake 
collapse. The vials located at the center of the shelves receive less heat and thus take a 
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longer time to dry than the corner or edge vials. The process must be run such that all vials 
are sufficiently dry, which is determined by center vials, and all vials are below the collapse 
temperature, which is determined by corner vials. 
There is a black box mathematical model that simulates primary drying. The model 
takes inputs of process time, chamber temperature, chamber pressure, vial location, and 
vial type. The chamber temperature was varied from -40 ˚C to 10 ˚C and pressure was 
varied from 10 Pa to 40 Pa to determine optimal conditions. The vial location options 
included center, edge, and corner. The vial types are 8R and 20 mL vials, which are treated 
as two separate products. The model provides outputs of drying time, maximum product 
temperature, and maximum sublimation rate. 
 The goal of this project is to decrease drying time as much as possible while 
producing the maximum number of vials at the lowest possible utility usage. 
Section 2.1.3 Economic Analysis 
 The main deliverable of this report details the cost savings from our proposed 
operating conditions against the base cases provided. In order to determine cost savings, 
operational cost models were constructed that converted operating conditions and process 
run times into annual costs for both FBG and lyophilization. Section 20 deals extensively 
with how these models were developed and used to provide recommendations. 
Additionally, to complete the profitability analysis, a comparison of depreciation schedules 
between the base case and proposed conditions is presented in order to see how reduced 
run times could lead to savings in equipment depreciation. Several assumptions were made 
throughout the development of the cost models which are all detailed later on this report.  
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Section 2.2 Project Charter 
Name of Project: Future API Manufacturing Excellence 
Project Author: Dr. Alex Marchut 
Project Advisors: Dr. Amish Patel and Professor Bruce Vrana 
Project Leaders: Emily Cunningham, Marc Geagea, and Rachel Wilson 
 
Specific Goals: 
 Design a faster and/or cheaper lyophilization primary drying process that 
satisfies all constraints for a new large molecule product, HAJVANOX 
 Optimize the granulation of a small molecule high-volume product, 
Botilioxin, by finding a global optimum in operation cost 
 
Lyophilization Project Scope: 
 In Scope 
 Produce 10,000,000 8R vials and 200,000 20 mL vials per year of product 
 Satisfy product quality requirements including maximum product 
temperature 
 Satisfy equipment capability constraints including minimum chamber 
pressure 
 Size and cost a vacuum pump 
 Calculate annual operational cost of base case and new case for both 8R and 
20 mL vial products 
 Determine depreciation savings and global optimum for profitability 
 
 Out of Scope 
 Freezing and secondary drying steps of lyophilization 
 Raw materials costs 
 Physical properties of products 
 Sizing and costing equipment including a condenser, refrigeration system, 
and electric heater 
 Scheduling production, cleaning, and changeover or calculating associated 
costs 
 Market and competitive analysis 
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Deliverables: 
 Operational conditions that show significant savings compared to the base 
case 
 Analysis of how different parameters such as chamber temperature, chamber 
pressure, and process time affect operational costs 
 
Fluid Bed Granulation Project Scope: 
 In Scope 
 Producing 250 batches per year of product  
 Satisfy moisture and quality requirements of the product 
 Maximize equipment capability 
 Calculate annual operational cost and savings for base case and 
recommended case 
 Determine depreciation savings and global optimum for profitability 
 
Out of Scope 
 Downstream manufacturing processes 
 Raw material costs 
 Sizing and costing a heater, fan, and filters 
 Physical properties of product 
 Scheduling production, cleaning, and changeover or calculating associated 
costs 
 Market and competitive analysis 
 
Deliverables 
 Operational conditions that show significant savings compared to the base 
case 
 Determining if increased efficiency of the process can be achieved  
 
Timeline: 
 January-February: Perform background research on both processes, form 
initial parameter boundaries 
 February-March: Finalize candidate test range, size and cost additional 
equipment, finish developing operational cost function for both processes 
 March-April: Calculate cost output for all test candidates, finalize 
recommendations 
 April: Write final report with findings 
 19 
 
 
 
 
 
Section 3: Innovation Map 
 
N/A 
This project does not involve any new material, process/manufacturing, or product 
technologies. This project rather involves the investigation of optimal process conditions 
for two pre-existing processes. There are no other changes being made to the pre-existing 
processes. Therefore, the innovation map section has been omitted from this report. 
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Section 4: Market and 
Competitive Analysis 
 
N/A 
The identities of the products being manufactured are unknown and all market information 
is proprietary. Therefore, the market and competitive analysis section has been omitted 
from this report. 
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Section 5: Customer 
Requirements 
 
N/A 
Customer requirements were found not to be applicable to this project. The market and 
product are not known, and therefore this section has been omitted from this report. 
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Section 6: Critical-to-Quality 
Variables 
 
N/A 
As stated in the previous section, the market for the products produced in this project and 
customer requirements are not known. Therefore, Critical-to-Quality Variables cannot be 
determined for this project. This section has been omitted from this report. 
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Section 7: Product Concept 
 
N/A 
No information was provided on the products manufactured using fluid bed granulation or 
lyophilization other than the names and the type of molecule. It was found that the focus of 
this project was not on the products being produced, but rather the operations and 
equipment needed to create the product. Therefore, the Product Concepts section has been 
omitted from this report. 
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Section 8: Superior Product 
Concept 
 
N/A 
As stated in the previous section, no products were created or manufactured during this 
project. Therefore, the superior product concepts section has been omitted from this 
report. 
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Section 9: Competitive 
Patent Analysis 
 
N/A 
There are no patents known of for any products being produced in fluid bed granulation or 
lyophilization. It was found that this information was not important in the application of 
this project. Therefore, the Competitive Patent Analysis section has been omitted from this 
report. 
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Section 10: Preliminary 
Process Synthesis 
 
N/A 
There are no alternative processes being considered for neither fluid bed granulation nor 
lyophilization. No new processes are being made so there are no process flowsheets or 
synthesis trees. Therefore, the preliminary process synthesis section has been omitted 
from this report. 
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Section 11: Assembly of 
Database 
 
N/A 
There are no chemical reactions being studied in this report. The properties of any raw 
materials being used are outside of the scope of this project. Therefore, the assembly of 
database section has been omitted from this report. 
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Section 12: Process Flow 
Diagrams and Material 
Balances 
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Figure 12.1. Required inputs and outputs for the fluid bed granulation simulation. The simulation box 
signifies the MATLAB “black box” model that was used throughout this project.  
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Figure 12.2. Process flowsheet for the fluid bed granulation process. More information regarding the process 
is available in Section 13.  
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Figure 12.3. Required inputs and outputs for the lyophilization simulation. The simulation box signifies the 
MATLAB “black box” model that was used throughout this project. 
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Figure 12.4. Process flowsheet for the lyophilization process. More information regarding the process is 
available in Section 13. 
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Section 13: Process 
Description 
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Section 13.1 Fluid Bed Granulation Simulation Description 
 
Figure 13.1.1. Piecewise representation showing how the FBG MATLAB model takes inputs in and gives 
outputs. This figure was provided via the original project statement. 
 
For fluid bed granulation, a “black-box” simulation model, run through MATLAB, 
was provided by the author. This simulation requires six inputs and produces two outputs. 
The six inputs are inlet air temperature for the spray step, inlet air temperature for the 
drying step, inlet air humidity, inlet air flow rate, spray rate, and phase duration. The two 
outputs given were Max Loss of Drying percentage and End Loss of Drying percentage. The 
inputs were entered into a matrix, and then run through the MATLAB simulation. Table 
13.1.1 describes the significance of each input and output more in detail.  
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Table 13.1.1 This table gives a brief description of the process parameters that were chosen for the 
simulation. The goal of this project was to narrow down which range of values for each input improved the 
process.  
Input Description  
Inlet Air Flow Rate Flow Rate of the air throughout the process 
Inlet Air Spray Temperature Temperature of the air coming out of the HX-01 and into the bed 
during the spraying step 
Humidity  Humidity of the ambient air coming into the process 
Inlet Air Drying Temperature  Temperature of the air coming out of the HX-01 and into the bed 
during the drying step 
Phase Duration Time duration of both the spraying and the drying steps in the 
process 
Binder Spray Rate  Spray rate of the binder being pumped out of P-01 
 
Section 13.2 Fluid Bed Granulation Equipment Flowsheet Description  
The process begins with ambient air being purified through filters (FL-01) before 
entering the manufacturing space. This filter is located at the inlet of the process. Once the 
air is filtered of bacteria and particulate matter, it flows through a condenser (CD-01) 
which is responsible for controlling the humidity of the air. The condenser runs 10˚C 
cooling water through a coil. Once the air reaches the appropriate humidity value, it is 
heated up using a countercurrent heat exchanger (HX-01). Steam is used to heat up the air 
to the required temperatures needed for the process. This steam is derived from the 
cooling water provided to the plant by heating it up using a traditional electric heater (H-
01).  
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During the spraying process, the inlet air temperature to the bed is 55˚C. This is held 
for the duration of the spraying process. For the drying portion, the air temperature is 
increased to 75˚C and held constant. The simulation provided does not account for the 
process having to achieve equilibrium or any controls. The time to reach equilibrium was 
estimated and incorporated into the utility and power requirements of the process. Since 
the T between the spraying and drying steps temperatures is 20˚C, an appropriate 
equilibration time was determined to be about 5 minutes.  
During the spraying process, the binder is pumped through a peristaltic pump (P-
01) to the bed (UNIT-01). The bed is lined with spray nozzles that evenly distribute the 
binder over the product. The binder is continuously sprayed for the duration of this part of 
the process. Based on the results compiled by the simulation, the optimal phase duration 
for the spraying section is 100 minutes. Air is being blown over the product during this 
step as well to encourage an even distribution of binder on the product.  
Once all of the binder has been sprayed on the product, drying occurs. During this 
step, air at 75˚C is continuously flowed over the product to dry the agglomerated particles. 
This phase duration was determined to be optimal in the range of 124-134 minutes. After 
all the product is dry, it is stored and transported to the next step in the manufacturing 
process. Any air leaving the processes passes through a particulate filter (FL-02) before 
reentering the environment. 
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Section 13.3 Fluid Bed Granulation Optimization Approach  
 The goal of this project was to optimize the process while producing product which 
fell within quality and product constraints. The only product constraints were the following 
mentioned in Table 13.3.1. 
Table 13.3.1. This table displays the product constraints recommended by the project author. These values 
were the outputs given for each simulation run through the MATLAB model. Loss of Drying signifies the 
moisture content that the product achieves during and at the end of the process.  
Loss of Drying (LOD) Percentage (%) 
Maximum 4.0-11.4 
End  2.0-3.5 
 
 For each of the simulations, the outputs would be the Maximum LOD%, End LOD%, 
and the phase duration of the spraying and drying steps. If the outputs did not fall within 
the ranges provided above, the inputs were determined to be unviable. 
In order to narrow down the inputs to the optimal values, an abbreviation of the 
full-factorial method was used. This method is traditionally used in statistics when an 
experiment has two or more factors, each with discrete values. Instead of performing a full 
factorial on six possible inputs for the simulation, the two factors used for the 
“abbreviated” method were temperature and air flow rate. It was decided to use these two 
inputs because both had wider ranges of values to simulate. Figure 13.3.1 shows a visual of 
this abbreviated method.  
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Figure 13.3.1. This figure gives a visual depiction of the abbreviate full factorial method used to narrow down 
the ranges of inputs to start with. The temperature values only correspond to the inlet temperature for the 
spraying step. The drying temperature was not taken into consideration. 
(https://www.itl.nist.gov/div898/handbook/pri/section3/pri3332.htm) 
 
The high inlet temperature is defined as 55˚C air during the spraying step. The low 
inlet temperature is defined as 46˚C for the inlet air during the spraying step. The high 
binder spray rate is defined as 900 (g/s) and low spray rate is defined as 750 (g/s). A series 
of simulations were run at each of the four corners while the other inputs values were held 
constant. It was found that the simulations that produced outputs falling closest to the 
product LOD% constraints were those that operated at smaller T values between 
spraying and drying temperatures and high binder spray rates. It was decided to focus on 
this range of values as a starting point in order to optimize all other values in the process. 
(55˚C, 1000g/s) 
(46˚C, 1000g/s) 
(55˚C, 800 g/s) 
(46˚C, 800 g/s) 
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The other simulations produced product that was too dry, low LOD%, and could not be 
viable. The results of all the preliminary simulations are in the Appendix.   
Once it was determined that successful simulations had high inlet air temperatures 
during the spraying step and high binder spray, other parameters were optimized. The next 
parameter tested was the phase duration of the drying time. The base case runs at a drying 
time of 175 minutes. With this process time, it was found that the product was still too dry 
after the operation was finished.  
In order to increase the moisture of the product, a series of simulations were run at 
lower drying times. The constraints on the drying time provided by the project instructions 
were 100-200 minutes. It was determined that the optimal drying times were between 
120-134 minutes. The results of the simulations altering the drying phase times are located 
in Appendix A.  
The binder spray rate was determined to be optimal at 900 g/s. This value was 
found to achieve the correct LOD% values needed for product quality.  
The inlet air humidity is a parameter that must be held constant at 7.6 g water/kg 
air. This value was used in all of the simulations that were ran for this project. There were 
some experiments using lower values of humidity, ranging from 3-6.2 g water/kg air. These 
tests were done because of how the condenser works in the real application of this project. 
Based on what was provided by the project author, the condenser operates with no 
humidity controls. This means that no matter what the ambient air humidity is, the air will 
still enter the process.  
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In order to ensure that the product would fall within LOD% constraints with any 
humidity air value, which in this climate can range from 3-20 g water/kg air, the other 
process parameters were optimized. A series of simulations were run at different humidity 
values, available in Appendix A. It was found that the humidity value did not have a 
significant effect on the final LOD% values of the product. Therefore, it was determined 
that the humidity should be held at a constant value for the process. As shown in the utility 
requirements section, the value is held constant at 7.6 g water/kg air.  
Section 13.4 Lyophilization Simulation Description 
 
Figure 13.4.1. Piecewise representation showing how the lyophilization MATLAB model takes inputs in and 
gives outputs. This figure was provided via the original project statement. 
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The simulation is run with MATLAB or MATLAB Runtime and requires three inputs 
in the form of a 3 x 3 matrix. The first column of the matrix is process time in hours, the 
second column is shelf temperature (˚C), and the third column is chamber pressure (Pa). 
Another input is vialGroup, which identifies the location of the group of vials for which the 
simulation is occurring. The options are center, corner, and edge. Corner vials receive the 
most heat because they are located near the chamber walls and thus receive more heat via 
radiation. Center vials receive the least heat because they are furthest from the chamber 
walls. The last input is vialType, which specifies whether the vial being used is 8R or 20 mL. 
These vials have different geometries and different heat transfer coefficients. The process 
must be optimized individually for 8R and 20 mL vials, since these are essentially two 
different products.  
The simulation has three outputs: drying time (h), peak product temperature (˚C), 
and maximum sublimation rate (g/s). The drying time is the amount of time necessary to 
sublimate at least 99.9% of the ice out of the vial. In order for a lyophilization run to be 
successful, every vial type (center, edge, and corner) must be dried to completion. It is 
expected that center vials will have the longest drying time since they are receiving the 
least heat, so the drying time of the center vials is used as the overall drying time for the 
process. There is no danger of excessive drying, so it alright if the corner and edge vials are 
dried before the center vials as long as they don’t exceed the collapse temperature.  
The peak product temperature is the maximum temperature that the product 
reaches during drying. This temperature must be below the collapse temperature, which is 
estimated to be approximately -20 ˚C. Because the corner vials are receiving the most heat 
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and thus will have the highest peak product temperature, the peak product temperature of 
the corner vials is used as a process constraint. 
The peak sublimation rate (PSR) of the vial, which is given in g/s, is the highest 
sublimation rate for any single vial during the run. The condenser can only remove a 
limited amount of water at a given time which creates a constraint for the peak sublimation 
rate. There is a given equation relating the minimum allowable chamber pressure, Pmin, to 
the total peak sublimation rate, PSRtot, which is the value obtained assuming all vials are 
operating at the peak sublimation rate. Because the corner vials are expected to receive the 
most heat when compared to edge or center vials, the PSR of the corner vials is used to 
determine Pmin. 
For N vials where N is between 10,000 and 60,000 vials: 
𝑃𝑆𝑅𝑡𝑜𝑡 (
𝑘𝑔
ℎ𝑟
) = 𝑁 ∗ 𝑃𝑆𝑅 ∗ 0.001
𝑘𝑔
𝑔
∗ 3600
𝑠
ℎ𝑟
 
Given this value of PSRtot, Pmin can be calculated using the following equation: 
𝑃𝑚𝑖𝑛(𝑚𝑡𝑜𝑟𝑟) = 𝑎 + 𝑏 ∗ 𝑃𝑆𝑅𝑡𝑜𝑡 + 𝑐 ∗ 𝑃𝑆𝑅𝑡𝑜𝑡
2  
𝑎 = 6.0071 𝑚𝑇𝑜𝑟𝑟 
𝑏 = 1.1752
𝑚𝑇𝑜𝑟𝑟 ∗ ℎ𝑟
𝑘𝑔
 
𝑐 = 0.2131 𝑚𝑇𝑜𝑟𝑟 ∗
ℎ𝑟2
𝑘𝑔2
 
The value of Pmin must be such that the pressure at which the chamber is operating, Pchamber, 
is greater than Pmin 
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𝑃𝑚𝑖𝑛 < 𝑃𝑐ℎ𝑎𝑚𝑏𝑒𝑟 
This equation is used to determine the maximum value of N, the number of vials, that the 
chamber can accommodate at the given process temperature and pressure. To be safe, we 
will require that Pmin be at least 1 Pa lower than the chamber pressure.  
Section 13.5 Lyophilization Equipment Flowsheet Description 
The product is contained in glass vials, 8R or 20 mL, which are loaded into the 
lyophilization chamber (UNIT-01). The chamber contains ten stainless steel shelves, each 
of which holds 1,000 to 6,000 vials for a total of 10,000 to 60,000 vials per batch depending 
on the selected batch size (GEA Group). The shelves are hollow and contain circulating 
silicon oil (SIO-01) that is used to change the temperature of the shelves and thus the vials 
(Low Temperature Silicon). The silicon oil runs through tubes that are connected to a 
circulating pump, an electric heater (H-01), and a refrigeration unit (R-01). During freezing, 
the silicon oil is cooled by the refrigeration unit. During primary and secondary drying, the 
silicon oil is heated by the electric heater. The lyophilization chamber is connected to a 
separate condenser chamber (CD-01) that is maintained at a significantly lower 
temperature. When the ice in the product vials sublimates, the vapor will preferentially 
move towards the condenser (Nireesha, 2013). In the condenser chamber, the vapor will 
immediately undergo deposition upon contact with the cooling coil. The cooling coil is 
hollow stainless steel that has cold silicon oil (SIO-02) running through it which is cooled 
by the refrigeration system. A vacuum pump (P-01) is attached to the condenser chamber 
that is responsible for decreasing the pressure of the lyophilization chamber from 
atmospheric pressure to the low pressures required for primary and secondary drying.  
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Section 13.6 Lyophilization Optimization Approach 
In order to narrow down the number of simulations that needed to be run, we took 
a modified factorial design of experiment approach. From literature, it was determined that 
the minimum operating pressure for this process is approximately 10 Pa and the maximum 
operating pressure is approximately 40 Pa (Ward, 2019). The minimum starting 
temperature that was considered was -30˚C and the maximum starting temperature that 
was considered was -5˚C.  
The first step of this project was determining a design space that includes all of the 
temperature and pressure combinations that satisfy both product constraints and 
equipment constraints (Office of Regulatory Affairs). Several preliminary simulations were 
run to identify four corners of the design space: high temperature and high pressure, high 
temperature and low pressure, low temperature and high pressure, and low temperature 
and low pressure (Bockstal, 2017).  
The design space for the 8R vial product was determined as follows: the high 
temperature and high pressure corner was identified at -9˚C and 40 Pa at which point the 
peak product temperature exceeded product quality constraints. The high temperature and 
low pressure corner was identified at -5˚C and 10 Pa at which point the equipment 
constraints allow only 30,000 vials per batch, making these conditions economically 
unfavorable.  The low temperature and high pressure corner was identified at -28˚C and 40 
Pa at which point the drying time was 40 hours, which significantly exceeds the drying time 
of the base case. The low temperature and low pressure corner was identified at -28˚C and 
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10 Pa at which point the drying time was 40 hours, which also significantly exceeds the 
drying time of the base case.  
Figure 13.6.1. This figure gives a visual depiction of the abbreviated full factorial method used to narrow 
down the ranges of inputs to start with for the 8R vial design space. 
 
The design space for the 20 mL vial product was determined as follows. The high 
temperature and high pressure corner was identified at 5˚C and 40 Pa at which point the 
peak product temperature exceeded the product quality constraints. The high temperature 
and low pressure corner was identified at -15˚C and 10 Pa at which point the equipment 
constraints allow only 10,000 vials per batch, making these conditions economically 
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unfavorable. The low temperature and high pressure corner was identified at -28˚C and 40 
Pa at which point the drying time was 35 hours, which significantly exceeds the drying time 
of the base case. The low temperature and low pressure corner was identified at -33˚C and 
10 Pa at which point the drying time was 30 hours, which is significantly higher than the 
base case and all other 20 mL vial simulations performed. 
 
Figure 13.6.2. This figure gives a visual depiction of the abbreviated full factorial method used to narrow 
down the ranges of inputs to start with for the 20 mL vial design space. 
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Once the design space was determined, every point within the design space ranging 
from -28˚C to -5˚C was tested at pressures of 10 Pa, 20 Pa, 30 Pa, and 40 Pa. The results are 
included in the appendix. The utility and labor requirements were calculated for each 
simulation based on the temperature and pressure conditions as well as process time. The 
total operational cost was determined for each point and the simulation with the lowest 
operational cost was used as the new case. For the 8R vial, this was the simulation 
occurring at a pressure of 30 Pa with T1=-9˚C and T2=1˚C.  
An additional constraint is the fact that both processes must use the same 
equipment. The electric heater, refrigeration system and condenser are all sized based on 
other processes within lyophilization and thus it is assumed that both vials use these same 
pre-existing pieces of equipment. The vacuum pump, however, will be sized depending on 
the most efficient operating pressure. This pressure will be determined based on operating 
conditions for the 8R vials rather than the 20 mL vials. 8R vials are a much higher volume 
product and thus the optimization of the 8R process will result in the greatest cost savings. 
The 20 mL vial operating conditions thus must use the pressure that is predetermined by 
the 8R vial optimum operating conditions. The operating pressure must therefore be 30 Pa. 
For the 20 mL vial, the most efficient operating conditions at 30 Pa occur at temperatures 
of T1=-9˚C and T2=1˚C. 
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Section 14: Energy Balance 
and Utility Requirements 
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Section 14.1 Fluid Bed Granulation 
 Energy balances are not applicable to this project. The major utility requirements 
for this process are electricity, cooling water, and steam. Because the product is being made 
in a pre-existing plant, utility supply systems are out of the scope of this project. Only utility 
requirements for operation will be discussed. All intrinsic variables were determined using 
Engineering Toolbox. The utility requirements are based on the aforementioned 
recommended operating conditions for this process. These recommendations are listed in 
Section 23 of this report.  
Table 14.1.1. Fluid Bed Granulation Base Case Utility Requirements per Batch 
Equipment Electricity 
Requirement (kw)  
Steam Requirement 
(kg/s) 
Cooling Water (kg/s) 
HX-01  .584  
CD-01 1.073  0.128 
P-01 .012   
H-01 1439 .584  
F-01 7.06   
Total 1447.145 1.168 0.128 
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Table 14.1.2. Fluid Bed Granulation Recommended Case Utility Requirements per Batch 
Equipment Electricity 
Requirement (kw)  
Steam Requirement 
(kg/s) 
Cooling Water (kg/s) 
HX-01  .636  
CD-01 1.11  0.132 
P-01 .013   
H-01 1568 .636  
F-01 7.31   
Total 1576.433 1.272 0.132 
 
 As displayed in the tables above, the utility requirements for each piece of 
equipment increased from the base case. This stems from the reduction in process time. 
Though the requirements increase, the time duration for the process decreases resulting in 
cost savings. More information regarding cost savings is presented in Sections 20 and 21.  
Section 14.2 Lyophilization 
Energy balances are not applicable to this project. The major utility requirements 
for this process are electricity and cooling water. Because the product is being made in a 
pre-existing plant, utility supply systems are out of the scope of this project. Only utility 
requirements for operation will be discussed. The utilities for each product’s base case 
operational conditions and new case operational conditions are shown below. For the 8R 
vial product, the new case requires 24.06 kW electricity more than the base case and 42 
gallons cooling water more than the base case. For the 20 mL vial product, the new case 
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requires 9.75 kW electricity more than the base case and 10,909 gallons of water less than 
the base case.  
Table 14.2.1. 8R Base Case Utility Requirements per Run 
  Electricity (kW) Cooling Water (gal) 
Electric Heater 28.56   
Condenser 21.79 30,916 
Vacuum Pump 5.09   
Total 55.44 30,916 
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Table 14.2.2. 8R New Case Utility Requirements per Run 
  Electricity (kW) Cooling Water (gal) 
Electric Heater 41.50   
Condenser 33.12 30,958 
Vacuum Pump 4.88   
Total 79.50 30,958 
 
Table 14.2.3. 20 mL Base Case Utility Requirements per Run 
  Electricity (kW) Cooling Water (gal) 
Electric Heater 24.83   
Condenser 16.72 20,618 
Vacuum Pump 5.09   
Total 46.64 20,618 
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Table 14.2.4. 20 mL New Case Utility Requirements per Run 
  Electricity (kW) Cooling Water (gal) 
Electric Heater 40.45   
Condenser 11.06 9,709 
Vacuum Pump 4.88   
Total 56.39 9,709 
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Section 15: Equipment List 
and Unit Descriptions 
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Section 15.1 Fluid Bed Granulation Equipment 
The equipment required to run fluid bed granulation includes: a condenser, heat 
exchanger, pump, heater, fan, and filters. It is assumed the the fluid bed granulator itself 
does not require any power. The power utilities of the individual pieces of equipment were 
determined to equate the total power required for the overall process. Each piece of 
equipment is manufactured of stainless steel to reduce contamination risks. More 
information regarding the operation of the equipment can be found in Section 13. 
Specification sheets for each piece of equipment can be found in Section 16. Specification 
data can be found in Section 17.  
Condenser 
Unit Name: CD-01 
Type: Cooling Coil Condenser 
Pressure: 1 atm  
Power: 2.22 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1  
Costing Data: Section 17.1 
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The condenser is used to control the humidity of the ambient air used in the 
process. As described in the process design, ambient air is filtered and run through the 
process to dry the product. Based on information provided by the project author, the 
condenser operates at a dew point of 7.6 g water/kg of air.   
Heat Exchanger  
Unit Name: HX-01 
Type: Counter-Current Heat Exchanger  
Pressure: 1 atm  
Power: 35.1 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1 
Costing Data: Section 17.1 
 
The heat exchanger is responsible for heating the air required for the process. After 
the air is condensed to meet the desired humidity level, it is then heated back up to the set 
point for the inlet air temperature into the bed. The air is on the shell side of the heat 
exchanger while steam is flown through the tube side. Steam is used to heat the air rather 
than water because water is not able to achieve the required temperature increase. Water 
can only be heated up to a maximum of 120˚F (~49˚C) due to the possibility of calcium 
deposition on the inside of the tubes.  
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The heat exchanger was sized based on the temperature requirements for the 
drying portion of the process. Through simulations, it was shown that an inlet air 
temperature of 75˚C during the drying step is the most efficient option because it reduces 
the drying time of the product.  
Steam Heater 
Unit Name: H-01 
Temperature Change: 130˚C 
Pressure: 1 atm  
Heat Duty: 44.4 kJ/mol 
Power: 1154 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1 
Costing Data: Section 17.1 
 
A heater is required for this process to make steam. The plant provides water at 
10˚C. To heat up the steam to the required temperatures, it was determined that a total Q of 
44.4 kJ/mol of heat was required. The maximum power that is needed to heat the water to 
steam is 1145 kW. More information regarding utility requirements can be found in Section 
16.  
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Pump 
Unit Name: P-01 
Type: Peristaltic Pump  
Pressure: 1 atm 
Material: Silicone Tubing  
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1 
Costing Data: Section 17.1 
 
The pump for this process is responsible for pumping the binder into the bed. Due 
to the low binder flow rates, a peristaltic pump is required. These pumps are best for 
solutions that are pumped at low flow rates and do not have high possibility of shearing. A 
pump was not able to be sized based on the provided literature, so a vendor was contacted. 
It was determined that the best pump for this operation is a pharmaceutical pump, 
Verderflex Vantage 3000 P EZ Model. This pump’s specifications fall within what is 
required for this process. Its maximum flow rate is 1.7 L/min. The pressure the pump 
operates at is assumed to be atmospheric (Verderflex).  
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Fan 
Unit Name: FN-01 
Type: Centrifugal Backward Curved Fan  
Power: 25.5 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1  
Costing Data: Section 17.1 
 
A fan is used to draw the air through all the required equipment and the bed. The 
fan sits at the end of the process, outside of the bed. It has the power to draw in ambient air 
through the filter and into the process. Based on literature, a centrifugal backward-curved 
fan was determined to be the best option. The specifications of these types of fans fall 
within the range of flow rates that is required of the process (Seider et. al., 2010) The 
optimal flow rate for the process is 2800 
𝑚3
ℎ
. This flow rate accounts for the pressure drops 
that are experienced when the air flows through the ambient air filter located at the start of 
the process.  
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Air Filter 
Unit Name: FL-01 
Pressure: 1 atm  
Material: HV HEPA Filter 
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1 
Costing Data: Section 17.1 
 
The purpose of this filter is to purify the ambient air that enters the process. In 
order to remove bacteria and particulate matter, the required mesh size is 0.22-0.44 
microns.  
Product Filter  
Unit Name: FL-02 
Pressure: 1 atm  
Material: HV HEPA Filter 
Specification Sheet: Section 16.1  
Design Calculation: Section 26.3.1 
Costing Data: Section 17.1 
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The purpose of this filter is to prevent product from leaving the fluid bed during 
operation. While the air is being blown over the product, the filter acts as a barrier between 
the bed and the outside environment. The recommended pore size of this filter is 2-7 
microns.  
Section 15.2 Lyophilization Equipment  
The lyophilization process requires the following equipment: the lyophilization 
machine and control panel, a circulating pump, an electric heater, a refrigeration system, a 
condenser, and a vacuum pump. The operational costs of the electric heater, refrigeration 
system and vacuum pump will be taken into account because these are significant energy 
sinks that differ from the base case. The only piece of equipment that will be sized and 
costed is the vacuum pump, since this is the only equipment that will change significantly 
in price based on primary drying operational conditions. The lyophilization machine, 
control panel, and circulating pump will have the same energy usage as the base case and 
thus the equipment size and cost will be the same. The sizing of the refrigeration system 
and condenser will be determined by the freezing step rather than primary drying, and 
therefore the sizing and costing of this equipment is out of the scope of this project. 
Similarly, the sizing of the electric heater will be determined by the secondary drying step 
rather than primary drying, and therefore the sizing and costing of this equipment is also 
out of the scope of this project. All equipment used in the lyophilization process will be 
made of stainless steel as is typical of the pharmaceutical industry. More information 
regarding the operation of the equipment can be found in Section 13. Specification sheets 
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for each piece of equipment can be found in Section 16. Costing data can be found in 
Section 17. 
Lyophilization Machine and Control Panel 
The lyophilization machine and control panel are used to program the process 
conditions for lyophilization. They are assumed to use negligible energy in comparison to 
the rest of the equipment. The operational costs, sizing and costing of this equipment are 
therefore out of the scope of this project. 
Circulating Pump 
The circulating pump is used to continuously pump silicon oil through the chamber 
shelves. The silicon oil is connected to a refrigeration system, an electric heater, and the 
chamber shelves. Because the same flow rate of fluid is used in the base case as well as the 
new case, the circulating pump will present no differences in operational cost or equipment 
cost and therefore these calculations are out of the scope of this project. 
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Electric Heater 
Base Case 8R Vial Heater 
Unit ID: H-01 
Type: Electric Heater 
Temperature Change: 35˚C 
Pressure: 1 atm  
Heat Duty:  1.62*106 kJ 
Power: 28.6 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
 
 
 
 
 
 
 
 
 
 
 
 64 
Base Case 20 mL Vial Heater 
Unit ID: H-01 
Temperature Change: 35˚C 
Pressure: 1 atm  
Heat Duty: 1.10*106 kJ 
Power: 24.8 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
 
New Case 8R Vial Heater 
Unit ID: H-01 
Temperature Change: 46˚C 
Pressure: 1 atm  
Heat Duty: 1.63*106 kJ 
Power: 41.4 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
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New Case 20 mL Vial Heater 
Unit ID: H-01 
Temperature Change: 46˚C 
Pressure: 1 atm  
Heat Duty: 1.38*106 kJ 
Power: 40.4 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
Costing Data: N/A 
 
The electric heater is used to heat the silicon oil that flows through the chamber 
shelves. The heater is used during primary and secondary drying to increase the product 
temperature, sublimate ice during primary drying, and evaporate any residual water 
during secondary drying. As was previously mentioned, the operational costs of the electric 
heater will be calculated but the sizing and costing are out of the scope of this project. An 
electric heater was chosen rather than a heat exchanger due its high efficiency and ability 
to provide heat slowly to low-temperature heat transfer fluids. 
During primary drying, the heater will be used to increase the temperature of the 
lyophilization chamber from -45˚C to the initial chamber temperature (T1), which will take 
approximately 1.5 hours. After 1.5 hours, the heater will be used to increase the 
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lyophilization chamber further from T1 to the final chamber temperature (T2) which will 
also take 1.5 hours. The chamber will stay at T2 for the remainder of the primary drying 
process. The heater must increase the temperature of the stainless steel shelves, the glass 
vials, and the product as well as supply enough heat for sublimation to occur. The electric 
heater has an efficiency of 90%. The heat duty and power are calculated in the appendix, 
section 26.3.  
Refrigeration System and Condenser 
Base Case 8R Vial Condenser 
Unit ID: CD-01 
Type: Cooling Coil 
Temperature Change: 10˚C 
Pressure: 1 atm  
Area: 0.553 m2 
Heat Duty: 1.58*106 kJ 
Power: 21.75 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
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Base Case 20 mL Vial Condenser 
Unit ID: CD-01 
Type: Cooling Coil 
Temperature Change: 10˚C 
Pressure: 1 atm  
Area: 0.553 m2 
Heat Duty: 1.05*106 kJ 
Power: 16.75 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
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New Case 8R Vial Condenser 
Unit ID: CD-01 
Type: Cooling Coil 
Temperature Change: 10˚C 
Pressure: 1 atm  
Area: 0.553 m2 
Heat Duty: 1.58*106 kJ 
Power: 33.13 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
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New Case 20 mL Vial Condenser 
Unit ID: CD-01 
Type: Cooling Coil 
Temperature Change: 10˚C 
Pressure: 1 atm  
Area: 0.553 m2 
Heat Duty: 5.28*105 kJ 
Power: 11.1 kW 
Material: Stainless Steel  
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
 
The condenser is used to cool the vapor coming out of the lyophilization chamber. It 
is a large cooling coil containing circulating silicon oil that is cooled by the refrigeration 
unit. Water vapor will preferentially enter the condenser chamber from the lyophilization 
chamber because of the lower temperature. Once the water vapor contacts the surface of 
the condenser, it will immediately turn into ice and drop out of the condenser. As 
aforementioned, the operational costs of the refrigeration system and condenser will be 
calculated but the sizing and costing are out of the scope of this project. 
 The surface of the condenser must be maintained at -55˚C. The system will be 
initially set at -45˚C from the freezing step and the refrigeration system must remove 
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enough heat from the condenser in order to reach -55˚C after 1.5 hours. The refrigeration 
system must remove enough heat to decrease the temperature of the stainless steel 
condenser to -55˚C, decrease the temperature of the water vapor, and convert the water 
vapor to ice. The refrigeration system has an efficiency of 80%. The heat duty and power 
requirements are calculated in the Appendix, section 23.6.  
Vacuum Pump 
Base Case 8R Vacuum Pump 
Unit ID: P-01 
Type: Screw Compressor 
Material: Stainless Steel 
Temperature: -55˚C 
Pressure Change: 101,299 Pa 
Work: 4.24 kW 
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
Costing Data: Section 17.2 
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Base Case 20 mL Vacuum Pump 
Unit ID: P-01 
Type: Screw Compressor 
Material: Stainless Steel 
Temperature: -55˚C 
Pressure Change: 101,299 Pa 
Work: 4.24 kW 
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
Costing Data: Section 17.2 
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New Case 8R Vacuum Pump 
Unit ID: P-01 
Type: Screw Compressor 
Material: Stainless Steel 
Temperature: -55˚C 
Pressure Change: 101,295 Pa 
Work: 4.06 kW 
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
Costing Data: Section 17.2 
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New Case 20 mL Vacuum Pump 
Unit ID: P-01 
Type: Screw Compressor 
Material: Stainless Steel 
Temperature: -55˚C 
Pressure Change: 101,295 Pa 
Work: 4.06 kW 
Specification Sheet: Section 16.2 
Design Calculation: Section 26.3 
Costing Data: Section 17.2 
 
The vacuum pump is used to achieve the extremely low pressures required by 
lyophilization. The pressures that were considered in the design space range from 10 Pa to 
40 Pa, putting this process in the medium vacuum range. The best suited vacuum pump for 
this range of pressures is the screw compressor, which is a dry vacuum pump capable of 
reaching pressures as low as 0.1 torr and achieving a volumetric flow rate at suction 
conditions between 50-1,400 ft3/min. Dry vacuum pumps are more efficient than other 
vacuum pumps, such as steam-jet ejectors or liquid-ring pumps, and they do not require 
working fluids that contribute to air pollution (Ryans, 2001). 
The size and cost of the vacuum pump will depend significantly on the operational 
pressure, and thus the sizing and costing of the vacuum pump is within the scope of this 
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project. The screw compressor will run at 6,000 rpm.  The work required by the base case 
pump is 4.24 kW and the work required by the new case pump is 4.06 kW, which is 
calculated in the Appendix, Section 23. The pump efficiency is approximately 70%. The 
purchase cost of the base case pump is $71,817 and the purchase cost of the new pump is 
$68,789. Since the difference in purchase cost is minimal relative to the total capital 
investment ($7.5 MM), the cost will not have a significant effect on the economics. 
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Section 16: Specification 
Sheets 
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Section 16.1 Fluid Bed Granulation Specification Sheets 
HX-01 Air Heat Exchanger 
Item No.  HX-01 
 
Design Data   
Type: Shell-in-Tube, Countercurrent, Fixed 
Head 
 
Effective Surface Area: .0086 m2  
LMTD: 176˚F (80.3˚C)  
Heat Transfer 
Coefficient:  
3.71 
𝑊
𝑚∗𝐾
  
Tube Side Material: Stainless Steel  
Shell Side Material: Stainless Steel   
No. Tubes/Pass:  1  
No. Passes: 1  
 
Materials  Cold In Cold Out  Hot In Hot Out 
Temperature (˚C) 12 75 110 140 
Pressure (atm) 1 1 1 1 
Vapor Fraction 1 1 1 1 
Mass Flow (kg/s) .552 .552 .623 .623 
Molar Flow (mol/s) 19.1  19.1 34.6 34.6 
Component Mass Flow      
         Air .552 .552   
         Steam    .623 .623 
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CD-01 Air Condenser 
Item No.  CD-01 
 
 
Design Data   
Type: Cooling Coil   
Effective Surface Area:  .0086 m2  
LMTD: 46.3˚F (7.95˚C)  
Heat Transfer 
Coefficient:  
207 
𝑊
𝑀∗𝐾
  
Tube Side Material: Stainless Steel  
Shell Side Material: Stainless Steel   
No. Tubes/Pass:  1  
No. Passes: 1  
*maximum air temperature value, assumptions based off of location’s weather   
 
Materials  Cold In Cold Out  Hot In Hot Out 
Temperature (˚C) 10 12 32.5* 12 
Pressure (atm) 1 1 1 1 
Vapor Fraction 1 1 0 0 
Mass Flow (kg/s) 1.36 1.36 .552 .552 
Molar Flow (mol/s) 75.5 75.5 30.6 30.6 
Component Mass Flow (kg/s)     
         Air  .552 .552   
         Water   1.36 1.36 
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H-01 Steam Heater 
 Item No.  H-01 
 
Design Data   
Type: Heater  
Q:  44.4 kJ/mol  
Power: 1,145 kW   
Material: Stainless Steel   
 
 
 
 
 
 
Materials  Cold In Cold Out 
Temperature (˚C) 12 75 
Pressure (atm) 1 1 
Vapor Fraction 0 1 
Mass Flow (kg/s) .623 .623 
Molar Flow (mol/s) 34.6  34.6 
Component Mass Flow    
         Steam  .623  
         Water .623  
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P-01 Binder Pump 
Item No.  P-01 
 
 
 
Design Data   
Type: Peristaltic Pump  
Flow Rate*:  900 g/s  
Power: 0.02 kW  
Material: Silicone Tubing   
*assuming the density of binder is equal to that of water  
 
 
 
 
Materials  Binder In  Binder Out 
Temperature (˚C) 25 25 
Pressure (atm) 1 1 
Vapor Fraction 0 0 
Mass Flow (g/s) 900 900 
Component Mass Flow    
         Binder (g/s) 900  
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FL-01 Ambient Air Filter 
Item No. FL-01 
 
 
 
 
 
 
 
 
Materials    
Pressure (atm) 1   
Volumetric Air Flow Rate (m3/h) 2800  
Component Mass Flow    
         Air (m3/h) 2800  
          2800  
Design Data   
Type: HEPA H13HV 24.24.12 Filter  
Pore Size:  .22 m  
Material: Mini-pleated Wet Laid Microglass  
Area: 430 ft2  
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FL-02 Product Filter 
Item No.  FL-02 
 
 
Design Data   
Type:  HEPA H13HV 24.24.12 Filter  
Pore Size:  7 m  
Material: Mini-pleated Wet Laid Microglass  
Area: 430 ft2  
 
 
 
 
 
 
Materials    
Pressure (atm) 1  
 0  
Volumetric Air Flow Rate (m3/hr) 2800  
    
Component Mass Flow    
         Air (m3/h) 2800  
          2800  
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FN-01 Air Flow Fan 
Item No. FN-01 
 
Design Data   
Type: Centrifugal Backward Curved Fan   
Fan Efficiency:  0.6  
Power: 25.5 kW   
Material: Stainless Steel   
Head: 19.31 (in. H2O)  
Electric Motor 
Efficiency: 
0.9  
 
 
 
 
 
Materials    
Pressure (atm) 0.97  
   
Volumetric Flow Rate (m3/h) 2800  
    
Component Mass Flow    
         Air (kg/h) 3553  
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Section 16.2 Lyophilization Specification Sheets  
H-01 Electric Heater (8R Base Case) 
Item No.  H-01 
 
 
Design Data   
Type: Heater  
Q:  1.62*106 kJ  
Power: 28.6 kW   
Material: Stainless Steel   
 
 
 
 
 
 
Materials  Cold In Cold Out 
Temperature (˚C) -45 -10 
Pressure (atm) 1 1 
Vapor Fraction 0 1 
Mass Flow (kg/s) N/A N/A 
Molar Flow (mol/s) N/A  N/A 
 84 
H-01 Electric Heater (20 mL Base Case) 
Item No.  H-01 
 
 
Design Data   
Type: Heater  
Q:  1.10*106 kJ  
Power: 24.8 kW   
Material: Stainless Steel   
 
 
 
 
 
 
Materials  Cold In Cold Out 
Temperature (˚C) -45 -10 
Pressure (atm) 1 1 
Vapor Fraction 0 1 
Mass Flow (kg/s) N/A N/A 
Molar Flow (mol/s) N/A  N/A 
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H-01 Electric Heater (8R New Case) 
Item No.  H-01 
 
 
Design Data   
Type: Heater  
Q:  1.63*106 kJ  
Power: 41.4 kW   
Material: Stainless Steel   
 
 
 
 
 
 
Materials  Cold In Cold Out 
Temperature (˚C) -45 1 
Pressure (atm) 1 1 
Vapor Fraction 0 1 
Mass Flow (kg/s) N/A N/A 
Molar Flow (mol/s) N/A  N/A 
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H-01 Electric Heater (20 mL New Case) 
Item No.  H-01 
 
 
Design Data   
Type: Heater  
Q:  1.38*106 kJ  
Power: 40.4 kW   
Material: Stainless Steel   
 
 
 
 
 
 
 
Materials  Cold In Cold Out 
Temperature (˚C) -45 1 
Pressure (atm) 1 1 
Vapor Fraction 0 1 
Mass Flow (kg/s) N/A N/A 
Molar Flow (mol/s) N/A  N/A 
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CD-01 Vapor Condenser (8R Base Case) 
Item No.  CD-01 
 
 
Design Data   
Type: Cooling Coil   
Effective Surface Area:  0.553 m2  
Material: Stainless Steel  
 
 
 
 
 
 
Materials  Cold In Cold Out  Hot In Hot Out 
Temperature (˚C) -55 -55 -10 -55 
Pressure (atm) 1 1 1 1 
Vapor Fraction 0 0 1 0 
Mass Flow (kg/s) N/A N/A 6.05*10-3 6.05*10-3 
Molar Flow (mol/s) N/A N/A 0.336 0.336 
Component Mass Flow (kg/s) 
     Water 
 
 
 
 
 
6.05*10-3 
 
6.05*10-3 
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CD-01 Vapor Condenser (20 mL Base Case) 
Item No.  CD-01 
 
 
Design Data   
Type: Cooling Coil   
Effective Surface Area:  0.553 m2  
Material: Stainless Steel  
 
 
 
 
 
 
Materials  Cold In Cold Out  Hot In Hot Out 
Temperature (˚C) -55 -55 -10 -55 
Pressure (atm) 1 1 1 1 
Vapor Fraction 0 0 1 0 
Mass Flow (kg/s) N/A N/A 4.64*10-3 4.64*10-3 
Molar Flow (mol/s) N/A N/A 0.258 0.258 
Component Mass Flow (kg/s) 
     Water 
   
4.64*10-3 
 
4.64*10-3 
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CD-01 Vapor Condenser (8R New Case) 
Item No.  CD-01 
 
 
Design Data   
Type: Cooling Coil   
Effective Surface Area:  0.553 m2  
Material: Stainless Steel  
 
 
 
 
 
 
Materials  Cold In Cold Out  Hot In Hot Out 
Temperature (˚C) -55 -55 1 -55 
Pressure (atm) 1 1 1 1 
Vapor Fraction 0 0 1 0 
Mass Flow (kg/s) N/A N/A 9.19*10-3 9.19*10-3 
Molar Flow (mol/s) N/A N/A 0.510 0.510 
Component Mass Flow (kg/s) 
     Water 
   
9.19*10-3 
 
9.19*10-3 
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CD-01 Vapor Condenser (20 mL New Case) 
Item No.  CD-01 
 
 
Design Data   
Type: Cooling Coil   
Effective Surface Area:  0.553 m2  
Tube Side Material: Stainless Steel  
 
 
 
 
 
 
Materials  Cold In Cold Out  Hot In Hot Out 
Temperature (˚C) -55 -55 1 -55 
Pressure (atm) 1 1 1 1 
Vapor Fraction 0 0 1 0 
Mass Flow (kg/s) N/A N/A 3.06*10-3 3.06*10-3 
Molar Flow (mol/s) N/A N/A 0.170 0.170 
Component Mass Flow (kg/s) 
     Water 
   
6.05*10-3 
 
6.05*10-3 
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P-01 Vacuum Pump (8R and 20 mL Base Case) 
Item No.  P-01 
 
 
Design Data   
Type: Screw Compressor  
Suction at flow:  0.0120 m3/s  
Power: 4.24 kW  
Material: Stainless Steel   
 
 
 
 
 
 
Materials  In  Out 
Temperature (˚C) -55 20 
Pressure (atm) 2.56*10-4 1 
Vapor Fraction 1 1 
Mass Flow (kg/s) 6.25*10-4 6.25*10-4 
Component Mass Flow (kg/s)   
         Air  6.25*10-4 6.25*10-4 
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P-01 Vacuum Pump (8R and 20 mL New Case) 
Item No.  P-01 
 
 
Design Data   
Type: Screw Compressor  
Flow Rate:  0.0103 ft3/min  
Power: 4.10 kW  
Material: Stainless Steel   
 
 
 
 
 
Materials  In  Out 
Temperature (˚C) -55 20 
Pressure (atm) 2.96*10-4 1 
Vapor Fraction 1 1 
Mass Flow (lb/hr) 6.25*10-4 6.25*10-4 
Component Mass Flow    
         Air  6.25*10-4 6.25*10-4 
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Section 17: Equipment Cost 
Summary 
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Section 17.1 Fluid Bed Granulation Equipment Cost Summary 
 No additional pieces of equipment needed to be sized for the fluid bed granulation 
portion of this project because no additional pieces of equipment needed to be purchased. 
The heater and the filters were not able to be costed. The pump cost was provided by the 
vendor. Some preliminary design calculations were made for a few pieces of equipment 
based on equations from the Product and Process Design Principles textbook (Seider). 
Please make note that due to the constraints of this process, it did not fall within the 
guidelines of the costing spreadsheet provided by Dr. Vrana and CBE 459. Because the 
costing spreadsheet was not used, the cost of the heat exchanger and condenser may differ 
from typical values.  Refer for Section 26.3.1 for more information.  
Table 17.1.1 Fluid Bed Granulation Equipment Costs 
Equipment Bare Module Cost Purchase Cost 
HX-01 $1,418,753.65 
 
$5,776,320.53 
CD-01 $12,006,523.71 $48,004,410.96 
 
F-01 $2,728.80 $9,891.9 
P-01 N/A $300-$500 
H-01 N/A N/A 
FL-01 N/A N/A 
FL-02 N/A N/A 
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Section 17.2 Lyophilization Equipment Cost Summary 
The only piece of equipment in lyophilization that must be separately sized and 
costed is the vacuum pump, which is a screw compressor. Vacuum size is mainly a function 
of pressure, and we would expect a vacuum pump that must reach lower pressures to cost 
more than a vacuum pump that must reach slightly higher pressures because it will take 
more energy to maintain a tighter pressure seal. This expectation is valid as the base case 
vacuum pump which operates at 26 Pa costs $284,397 whereas the new case vacuum 
pump which operates at 30 Pa costs significantly less at $272,406. The savings in 
equipment cost that result from changing operation conditions are $11,991. 
Table 17.2.1 Bare Module Cost of Vacuum Pumps 
  8R Vial 20 mL Vial 
Base Case $284,397 $284,397 
New Case $272,406 $272,406 
 
The purchase cost of the base case pump is $71,817 and the purchase cost of the new case 
pump is $68,789. A materials factor cost of 2 was used because the pump is made out of 
stainless steel. A bare-module factor of 3.30 was used, as is typical for any type of pump. A 
site investment factor of 1.20 was used because the vacuum pump will be located in a site 
in Switzerland. The total factor that the purchase cost was multiplied by was 7.92, 
accounting for the material, equipment type, and site location. Detailed calculations are 
included in the Appendix, section 26.3. 
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Section 18: Scheduling 
 
N/A 
Production scheduling is out of the scope of this project. Therefore, the scheduling section 
has been omitted from this report. 
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Section 19: Fixed Capital 
Investment Summary 
 
N/A 
There was determined to be no significant additional fixed capital investment to the base 
case. Therefore, this section has been omitted from the report. 
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Section 20: Operating Cost 
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Section 20.1 General Methodology 
 For the purposes of this design project, operating cost was not calculated as a fixed 
percentage of total capital investment. Because the main findings and recommendations 
derived from the analysis involved varying sensitivities to operational cost under certain 
operating conditions, operational cost models for both lyophilization and FBG were 
constructed in order to delineate between cost savings for proposed conditions. There 
were two main components of the operational cost model for both work streams: labor and 
utility costs. Raw material and byproduct costs are not within scope to the proprietary 
nature of the processes. Our economic model converts input conditions for the process into 
calculated operational cost on a per year basis with fixed batch sizes and yearly product 
requirement. The main underlying assumption of our calculation is that our processes only 
incurs cost when in use. It is assumed that when our process isn’t in use, the same 
equipment could be used to run a different process in the plant. Thus, labor costs, for 
example, are calculated as the percentage of an employee's total salaries based on the time 
spent operating our processes of focus. Additionally, the only utilities considered for both 
processes are electricity and water. The following subsections walk through the cost 
breakdowns for the base cases to give an understanding of how operational cost was 
calculated. 
Section 20.2 Fluid Bed Granulation Methodology 
 Inputs for the fluid bed granulation economic model include process run time, 
ambient air humidity and temperature (seasonal), inlet airflow rate, drying stage inlet air 
temperature, and binder spray rate. The model outputs labor cost and utilities costs broken 
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down by electricity and water requirement on an annual basis (based on batch 
requirements) as well as cost per kg of product produced. A summary of the the inputs and 
cost outputs for the base case can be seen in Figure 20.2.1 below.  
 
Figure 20.2.1. Operational cost summary for the base case during summer months with annual and per dose 
costs shown. 
 
Figure 20.2.1 shows the operational cost summary for the base case during an average 
summer month in China. Because the inlet air humidity and temperature is dependent on 
daily ambient conditions, it will fluctuate throughout the year. However, in order to 
compare to the base case, the inlet air humidity was assumed to be a constant of 7.6 g 
water/kg air because the condenser operates with no humidity constraints. Refer to 
section 13.2 to for a more detailed explanation of why the air humidity was held constant. 
Again for the purposes of a comparison to the base case, average temperature for summer 
months and winter months were assumed as 23˚C and 5˚C based on historical data 
(Weatherspark, 2019). Throughout this subsection, only the summer month conditions will 
be of focus. The actual yearly operational cost, which can be seen in section 20.4.1, was 
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calculated as the weighted average of the summer and winter months cost. Figure 20.2.2 
displays the detailed labor costs for the base case in the summer months. 
 
Figure 20.2.2. Labor cost summary for the base case with calculated costs per run and dose of $35.94 and 
$0.002. 
 
 In calculating labor costs, some basic assumptions about shift lengths, working days 
per month, overtime shifts, and wage benefits were made. For an average operator earning 
$1500 per month in China, with a 50% benefits rate, 8 hour shift length, 22 working days 
per month, and 1 overtime shift, the actual hourly rate of an operator comes out to 
$12.78/hr (Kelly Services, 2017). The lower value relative to US wage rates is consistent 
with labor data in China. Further, for any FBG run, it was assumed that two operators spent 
60% of the process time actually incurring costs based on recommendations from the 
project author. Using these assumptions, the hourly adjusted wage of a plant operator with 
overtime and benefits included is applied to the operator time at the process to calculate 
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the labor cost per run at $35.94. Figure 20.2.3 shows in similar detail how the utility costs 
were determined. 
 
Figure 20.2.3. Utility cost summary for the base case shown with electricity and water costs amounting to 
$326.50 and $2.85 per run respectively 
 
The utility costs were calculated based on the power requirements of the fan, 
condenser, heater/heat exchanger system, and pump. For an explanation of how the power 
requirements were determined, refer to section 13 of this report. Separate spreadsheets 
within the same model take the principles laid out in this section and use the process 
 103 
inputs to provide the power requirement for each set of operating conditions. The general 
approach took the power requirement after an efficiency factor was applied and multiplied 
it through the amount of time that the piece of equipment was assumed to be operating. All 
of the equipment was assumed to be operating for 105% of the process time to account for 
startup times. Using an average industrial rate for electricity prices in China, the total 
electricity costs were calculated on a per run basis to be $326.50 (CEIC, 2018). The only 
water required for the process is fed into the electric heater for conversion to steam that is 
used in the heat exchanger. The water costs are calculated from steam requirement of the 
heat exchanger which is supplied by the steam produced from the electric heater. With 
water available at 10˚C for this plant, the average industrial price of water is applied to the 
total water requirement to determine the costs per run at $2.85 (World Bank, 2017). 
Appendix 26.6 deals further with how these power functions and the water requirements 
are handled in relation to the economic model. Figure 20.3.1 shows how the 
aforementioned labor and utility costs are summed for the 250 annual batch requirements 
to output an annual operational cost. Since this particular generic requires a dose of 0.025 
kg, the cost per dose is also provided at $0.02.  
Section 20.3 Lyophilization Methodology 
 Inputs for the lyophilization economic model include process run time, operating 
pressure, number of vials, power requirements for the electric heater and 
condenser/refrigerator system. Because of the complexity required in calculating power 
for the heater and refrigeration, the power calculations were done discreetly and externally 
to the model for all the possible test cases. The model outputs a total labor and utilities cost 
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for 8R and 20 mL vials given known annual batch requirements as well as a cost per vial of 
product. Figure 20.3.1 below details the operational cost summary for the base case of this 
process.  
 
Figure 20.3.1. Operational cost summary for the base case with cost broken down by source and vial type. 
 
As can be seen from the figure, the total operating cost under these conditions are 
$139,440 for 8R vials and $4,183 for 20 mL vials amounting to a total of $143,623 per year. 
It’s important to note that the base case operating conditions do not differ for 8R or 20ml 
vials whereas our proposed conditions do differ slightly in this aspect. Similarly to FBG, the 
labor costs were calculated solely as a function of process time. Figure 20.3.2 shows how 
the labor costs were calculated. The big differences worth noting between the FBG and 
lyophilization labor costs were the significantly higher operator wages in lyophilization 
which is consistent with the current wage disparities between Switzerland and China.  
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Figure 20.3.2. Labor cost summary for the base case with calculated costs per run and vial of product of 
$328.50 and $0.006.  
 
The same assumptions for the number of working days per month, benefits, overtime 
shifts, and shift lengths used in FBG were applied here. It was additionally assumed that 
two operators spent 15% of the process run time incurring labor costs. Using the same 
cascade of calculations for labor detailed in section 20.2, labor costs per run and per vial of 
product were calculated at $328.50 and $0.006 for the base case (Glassdoor, 2019). The 
other main component of this model is the utility cost. Utility costs arise from the electricity 
usage of the refrigerator/condenser, electric heater, and vacuum pump as well as the water 
costs required for running the refrigerator. Figure 20.3.3 contains the detailed utility cost 
breakdown for the base case. 
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Figure 20.3.3 - Utility cost summary with $279.42 and $228.78 in electricity costs and water costs per run 
summing to $508.20 in total utility costs per run. 
 
Like for FBG, the electricity costs are calculated from a combination of the power 
requirement of the equipment, process time, and average electricity cost per kWh in 
Switzerland (Market Intelligence Group, 2016). For an explanation of how the power 
requirement for each piece of equipment was calculated, see equations located in section 
13 of this report. Referring back to Figure 20.3.1, the costs across utilities and labor per are 
summed and applied to number of required vials per year to obtain an operating cost. 
Section 20.4 Main Cost Drivers 
 A summary of the base case costs can be seen in Table 20.4.1. In order to propose 
the conditions with the greatest cost savings, the operational cost of the base case was 
compared to the cost for many different conditions. The recommended conditions with the 
greatest observed cost savings are dealt with later on in Section 21. However, in finding 
these conditions, trends among the main cost drivers in each process are discussed here to 
give general recommendations of how to optimize similar processes. 
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Table 20.4.1. Summary of the yearly/per product operational costs for the base case across both processes 
Case Process 
Labor costs 
($/year) 
Utility costs 
($/year) 
Operational cost 
($/year) Cost per dose ($) 
Base Lyophilization (8R) $54,750.70 $84,689.92 $139,440.62 $0.01 
Base Lyophilization (20ml) $1,642.52 $2,540.76 $4,183.22 $0.02 
Total Lyophilization $56,393.22 $87,230.68 $143,623.90 - 
Base FBG (summer) $13,062.01 $82,336.20 $95,398.21 $0.02 
Base FBG (winter) $13,062.01 $111,612.00 $124,674.01 $0.03 
Total FBG $13,062.01 $96,974.10 $110,036.11 - 
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Section 20.4.1 Fluid Bed Granulation 
 The two main cost drivers identified for fluid bed granulation were process time and 
inlet airflow rate. A comparison of the cost breakdown for the base and optimal conditions 
(see section 21) is presented in Figure 20.4.1. 
Figure 20.4.1. Cost components by percentage of the base and optimal cases 
The biggest component of operational cost arises from the electricity usage. After further 
investigation within the economic model, the heater and heat exchanger account for more 
than 98% of the electricity costs. The power requirement for these two pieces of 
equipment is driven by mainly the inlet air flow rate since it is used to calculate the heat 
duty required to heat the air to the appropriate drying temperature. Since the power usage 
is a function of process time as well, minimizing the inlet airflow rate and process run time 
would lead to the greatest operational cost savings.  
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Section 20.4.2 Lyophilization 
A similar analysis to the one above was performed on the economic model for 
lyophilization to determine what was driving the cost.  
Figure 20.4.2. Cost components by percentage of the base and optimal cases 
Figure 20.4.2 details the cost breakdown by component. Unlike in FBG, labor and water 
play a much bigger role in the determination of the cost. Since labor is only a function of 
process time, it was identified early on as a main driver of the cost for this process. Within 
electricity, the electric heater and condenser accounted for around 90% of the costs. 
Additionally, water costs arise only from the use of the condenser which is a function of 
condenser power and process run time. Since the condenser has a sizeable impact on both 
the electricity and water costs, it was prioritized in order to reduce costs. Thus, increasing 
shelf temperatures and lowering process run times were the main cost reducers in this 
process. 
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Section 21.1 Analysis of Fluid Bed Granulation Profitability 
 The profitability of the proposed operating conditions are discussed at length in this 
section. First, we consider the observed operational cost savings from the most promising 
proposed conditions. Table 21.1.1 below shows the annual and 15-year operational cost 
savings against the base of the proposed conditions. 
Table 21.1.1. Annual and 15-year operational cost savings from two proposed operating conditions 
Case 
Process 
time 
(min) 
Inlet air 
humidit
y (g/kg) 
Inlet airflow 
rate 
(m^3/h) 
Drying air 
temperature 
(C) 
Spray 
rate 
(g/min) 
Annual 
Operationa
l Cost 
15-year 
Operational 
Cost 
15-year 
Savings 
Base 200 7.6 2500 72 1200 $110,036.10 $1,650,541.50 - 
Popt 124 7.6 2800 75 900 $78,900.12 $1,183,501.80 $467,039.70 
P2 124 7.6 2900 75 900 $81,428.67 $1,221,430.05 $429,111.45 
 
For the condition Popt, which prioritizes lowering the process run time at the expense of a 
higher inlet airflow rate, the 15-year cost savings amount to $467,039, which is a fair 
amount for a generic process that has been in operation already for several years. P2 is 
shown to demonstrate the cost saving sensitivity to the inlet airflow rate. Aside from 
operational cost savings, we identified further savings in the depreciation of the equipment 
due to the reduced process run times. The total capital investment for the process is $7.5 
MM. Because our proposed operating conditions do not require equipment that is 
significantly more expensive than those of the base case, the capital investment remains at 
$7.5 MM. 
With an original end time of 200 min per batch, this process accounted for 13.3% of 
the total available time of the equipment. Under the 124 min proposed conditions, that 
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percentage drops to 8.25%. Thus, the equipment theoretically should depreciate at a lower 
rate as a result of the proposed conditions. Table 21.1.2 compares the difference in 
depreciation according to the 20-year MACRS schedule (used by parent company of project 
author) between the base case and the P1 operating condition.  
Table 21.1.2. Comparison of book-value depreciation between the base case and Popt 
Year 
20-year 
MACRS 
Book value 
(100%) 
Base Case 
(13.3%) Popt (8.3%) Savings 
Savings/min 
reduced 
1 3.75% $281,250.00 $37,416.09 $23,198.03 $14,218.06 $187.08 
2 7.22% $541,500.00 $72,038.45 $44,663.95 $27,374.50 $360.19 
3 6.68% $501,000.00 $66,650.54 $41,323.43 $25,327.10 $333.25 
4 6.18% $463,500.00 $61,661.72 $38,230.36 $23,431.36 $308.31 
5 5.71% $428,250.00 $56,972.24 $35,322.87 $21,649.37 $284.86 
6 5.29% $396,750.00 $52,781.64 $32,724.69 $20,056.94 $263.91 
7 4.89% $366,750.00 $48,790.59 $30,250.24 $18,540.35 $243.95 
8 4.52% $339,000.00 $45,098.87 $27,961.36 $17,137.50 $225.49 
9 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
10 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
11 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
12 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
13 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
14 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
15 4.46% $334,500.00 $44,500.21 $27,590.20 $16,910.01 $222.50 
Totals 75.46% $5,659,500.00 $752,911.58 $466,806.31 $286,105.27 $3,764.54 
 
Over the 15 year period of interest, the savings in book-value of depreciation amount to 
$286,105. These savings arise from the reduction of process time as can be seen from the 
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savings/minute of process time reduced column. Combining the book-value savings with 
the operational cost savings, our proposed condition, Popt, amounts to $753,144 in savings 
over the 15-year life of the equipment.  
 Because of the proprietary nature of this project, no sales or full cost of manufacture 
data is available for this product making use of the profitability analysis spreadsheet 
impossible. Thus, analyzing the effect of Popt on many of the standard profitability measures 
such as ROI and IRR is not within the scope of this report. However, a sensitivity analysis 
on the NPV was performed by making assumptions about selling price and cost to 
manufacture based on the average selling price of generic small molecules as described by 
the equation below.  
𝑃𝑟𝑜𝑓𝑖𝑡 𝑀𝑎𝑟𝑔𝑖𝑛 =
 𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑠 − 𝐶𝑜𝑠𝑡𝑠
𝑅𝑒𝑣𝑒𝑛𝑢𝑒𝑠
 
Assuming a selling price of $1.00/dose and 90% profit margins based on recommendations 
from industrial consultants, Figure 21.1.1 shows the effect on NPV in the over the last 6 
years of the project life under 4 cases: base, Popt, 7.5% operational cost savings, and 30% 
operational cost savings. Several additional assumptions were made in order to make this 
analysis possible - all the capital investment occurred in 2018 (year prior), 15% of the total 
depreciable capital was assumed to be working capital, and a 15% discount rate was 
applied. The total depreciable capital and resulting depreciation was varied depending on 
the usage rate of the process of the FBG equipment. For each case, the annual operational 
cost and depreciation were applied to the values of the base case. The effect on NPV at year 
15 was observed. For a comprehensive summary of the cash flows, refer to appendix 
section 26.7. 
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Figure 21.1.1. NPV comparison over the last 6 years of project life for each operating case. 
 
Only the last 6 years of the project are shown in the figure in order to show areas of 
clear deviation from the base case. Popt represents operational cost savings of 28.3% of the 
base. Assuming that revenues and non-operational costs remain constant throughout the 
15 year life, Popt represents a 1.88% increase in NPV over the base case. The low relative 
percentage change is expected due to the savings in operational cost and depreciation only 
representing a percentage of the cost. Table 21.1.3 below shows the sensitivity of NPV to 
operational cost savings cases.  
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Table 21.1.3. NPV sensitivity to different operational cost savings scenarios 
Case NPV Increase % NPV Increase NPV Increase/% cost saved 
Base - - - 
10%  $  186,430.73  1.16%  $                                 18,643.07  
Popt (28.3%)  $  302,970.72  1.88%  $                                 10,705.68  
35%  $  303,230.31  1.89%  $                                 10,714.85  
 
As savings theoretically surpass those offered by Popt, there are only marginal gains in NPV 
as evidenced by the 0.01% increase in NPV between the 28.3% and 35% case. Thus, further 
optimizing past our proposed conditions would not lead to great gains in profitability. 
Refer to section 21.2.3 to see notes about the results and shortcomings of this analysis 
across both processes. 
 
Section 21.2 Analysis of Lyophilization Profitability 
Proposed Operating Conditions  
Table 21.2.1. Popt proposed for lyophilization broken down by vial type 
Vial 
Shelf Temperature 
1 (C) 
Shelf Temperature 
2 (C) Vials/batch 
Process Run Time 
(hr) 
Pressure 
(Pa) 
8R -9 1 60000 16.6 30 
20ml -9 1 50000 15.6 30 
 
Table 21.2.1 exhibits the proposed operating conditions for the 8R and 20ml vials. 
Although the optimization of these two vial types was approached separately, the optimal 
shelf temperatures and pressure were the same. However, the 8R vials should be run at 
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60000 vials/batch and for an hour longer than 20ml.  A comparison of the annual and 15-
year cost savings against the base case of Popt is shown in Table 21.2.2. 
Table 21.2.2. Annual and 15-year operational costs of the base and recommended cases. 
Case Annual Operational Cost Annual Savings 15-year Operational Cost 15-year Savings 
Base  $                           143,623.90   -   $                       2,154,358.50   -  
Popt  $                           120,042.68   $          23,581.22   $                       1,800,640.20   $      353,718.30  
 
Popt prioritizes lowering the process run time at the expense of higher power usage by the 
condenser and electric heater. The operating pressure is increased from the base case by 4 
Pa in an effort reduce the cost associated with the vacuum pump. The increased pressure is 
accounted for by the 10˚C higher refrigerator shelf temperatures. The resulting operational 
cost savings amount to $23,581 annually and $353,718 over 15 years. The total capital 
investment for the process was again $7.5 MM. Our anticipated equipment for the proposed 
conditions does not require any non-negligible amount of capital investment. Due to the 
lower process time, the equipment will be available for other processes for more time 
annually. This lower usage rate results in further savings in depreciation. Table 21.2.3 
shows the expected book value of depreciation and resulting savings. 
 
 
 
 
 
 
 
 
 117 
Table 21.2.3. Comparison of book-value depreciation between the base case and Popt based on different 
annual usage rates of the equipment 
Year 
20-year 
MACRS 
Book value 
(100%) 
Base Case 
(68.4%) 
Popt (45.2%) Savings 
Savings/hr 
reduced 
1 3.75% $281,250.00  $192,375.00  $127,125.00  $65,250.00  $7,092.39  
2 7.22% $541,500.00  $370,386.00  $244,758.00  $125,628.00  $13,655.22  
3 6.68% $501,000.00  $342,684.00  $226,452.00  $116,232.00  $12,633.91  
4 6.18% $463,500.00  $317,034.00  $209,502.00  $107,532.00  $11,688.26  
5 5.71% $428,250.00  $292,923.00  $193,569.00  $99,354.00  $10,799.35  
6 5.29% $396,750.00  $271,377.00  $179,331.00  $92,046.00  $10,005.00  
7 4.89% $366,750.00  $250,857.00  $165,771.00  $85,086.00  $9,248.48  
8 4.52% $339,000.00  $231,876.00  $153,228.00  $78,648.00  $8,548.70  
9 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
10 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
11 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
12 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
13 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
14 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
15 4.46% $334,500.00  $228,798.00  $151,194.00  $77,604.00  $8,435.22  
Totals 75.46% $5,659,500.00 $3,871,098.00 $2,558,094.00 $1,313,004.00 $142,717.83 
 
Lyophilization has a much higher usage rate compared to FBG due to the longer process 
times. By optimizing around the process time, an additional $1.3 MM in depreciation 
savings over the 15-year life of the equipment was identified. In total, $1.67 MM in 
operational and depreciation cost savings were identified for our recommendations.  
Since the same proprietary measures apply to lyophilization, a similar sensitivity 
analysis on the NPV of this project over the 15-year life was performed excluding ROI and 
IRR measures. The selling price was assumed to be $10/dose, much higher than for FBG, 
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because of this product’s status as a patented biologic, but again is subject to high 
variability. A 90% profit margin was again assumed and the total costs were calculated 
using the same formula as for FBG. The same methodology for NPV analysis was applied 
here as earlier in section 21.1 and the complete cash flows can be found in appendix 26.7. 
Four operational cost scenarios were again studied: base case, 7.5% savings, Popt (16.4% 
savings), and 30% savings. Figure 21.2.1 shows the NPV over the last 6 years of the project 
life in order to differentiate between cases.  
 
Figure 21.2.1 - NPV comparison over the last 6 years of project life for each operating case. 
 
The results of this analysis closely mirror those of FBG. Popt in this case represented 16.4% 
of annual operational cost savings. For savings past the recommended conditions, the gain 
in NPV is marginal. Table 21.2.4 shows the gains in NPV across the test cases with the 
recommended case generating a 5.4% increase in NPV at the end of the project life.  
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Table 21.1.3. NPV sensitivity to different operational cost savings scenarios 
Case NPV Increase % NPV Increase NPV Increase/% cost saved 
Base - - - 
7.50%  $     987,710.90  2.70%  $                               131,694.79  
Popt (16.41%)  $ 1,984,715.11  5.43%  $                               120,945.47  
30%  $ 2,074,146.15  5.67%  $                                 69,138.20  
 
The marginal increase in NPV past the recommended conditions are consistent with what 
was observed in FBG indicating that further optimization would have little effect on 
increasing the NPV of this investment. While the magnitude of the NPV in this process 
reaches ~$38 MM, little can be made of it because the dependency on the selling price 
assumptions. 
Section 21.3 Profitability Caveats 
The results of this analysis for both FBG and lyophilization should be weighed 
against the validity of the assumptions made. Absolute values of NPV are not accurate of 
what the true values are. The relative values and aforementioned trends, however do 
provide some insight into how our proposed conditions could affect the NPV of this project. 
The effect of the selling price assumption on the NPV was mitigated by keeping the revenue 
and non-operational cost values constant. Thus, if selling prices and non-operational cost 
assumptions are somewhat within of the actual values, then the trends observed should 
hold. 
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Section 22.1 Environmental Considerations 
Pharmaceutical manufacturing practices tend to use a large amount of utilities 
including cold water, steam, and electricity, resulting in very high energy and water usage 
demands. Both processes described in this report use a large amount of energy and water, 
although lyophilization tends to be more energy-intensive. The objective of this project is 
to find optimal operating conditions for both products, which oftentimes translates into 
shorter process times and decreased utility usage. Although creating more environmentally 
friendly practices was not the main goal of this project, it is a fortuitous result of creating 
more economically favorable practices. 
The sites of operation described in this paper follow current Good Manufacturing 
Practice (cGMP) recommendations for waste disposal, meaning that all waste from both the 
fluid bed granulation and lyophilization processes is safely treated within the 
manufacturing site before being exposed to the outside environment. Both processes use 
the cleaning in place and steaming in place practices that are required by GMP guidelines. 
One major environmental and safety concern in fluid bed granulation is dust 
production. Dust is problematic because it could either contaminate the production of 
other drugs in nearby areas or it could escape into the environment where it would also 
have detrimental effects. The fluid bed granulation machine in this process has a dust 
sensor on the exhaust pipe. If the sensor detects a minimum mass, then the entire process 
will automatically shut down and the operators will determine the cause of the leak. This 
sensor ensures that essentially all waste from the fluid bed granulation process is 
contained. 
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An additional environmental improvement in the lyophilization process is the use of 
a dry vacuum pump for the vacuum system rather than a steam-jet ejector or a liquid-ring 
pump. Unlike the other two systems, the dry vacuum pump does not use any working fluids 
such as steam, water, or oils. The use of these fluids requires extra utilities and also 
contributes to air pollution, so the screw compressor is a more environmentally friendly 
option. 
Section 22.2 Good Manufacturing Practices 
Although the fluid bed granulation and lyophilization product are manufactured in 
China and Switzerland, respectively, the company is based in the United States and thus the 
products follow US requirements. ISPE defines Good Manufacturing Practice (GMP) as “a 
system for ensuring that products are consistently produced and controlled according to 
quality standards. It is designed to minimize the risks involved in any pharmaceutical 
production that cannot be eliminated through testing the final product. GMP covers all 
aspects of production from the starting materials, premises, and equipment to the training 
and personal hygiene of staff. Detailed, written procedures are essential for each process 
that could affect the quality of the finished product. There must be systems to provide 
documented proof that correct procedures are consistently followed at each step in the 
manufacturing process - every time a product is made (ISPE).” 
Both sites have a barcode scanner to scan every excipient that is added to the drug 
formulation. If the barcode is incorrect, the entire system will shut down. This ensures that 
no incorrect ingredients will ever enter the manufacturing process. The sites are both 
capable of handling the most potent pharmaceutical products. Although neither product 
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described in this report requires this much caution, these safety standards are used for all 
operations. 
All processes and products are completely isolated from each other and it can be 
assumed that both the lyophilization and fluid bed granulation equipment described here 
are dedicated to only one product. The operators all have sufficient personal protective 
equipment such that they risk no exposure to the drugs and there are no safety concerns 
for personnel. The air entering the fluid bed granulation process is filtered such that it is 
sterile and safe for pharmaceutical manufacturing. 
The main product quality constraint for the fluid bed granulation process is the 
percent of loss on drying for which there is a process maximum and a final constraint. Loss 
of drying is an important variable because the purpose of fluid bed granulation is to 
improve flowability and compressibility. If the granulation product is too dry or too wet, 
then these properties will not be improved and the downstream manufacturing processes 
will be compromised. In order to ensure that the product falls within quality constraints, 
the controlled inputs need to be carefully controlled. 
The main product quality constraint for the lyophilization process is the peak 
product temperature, which is the maximum temperature reached by any product vial in a 
single batch during primary drying. The peak product temperature for this process has 
been assumed to be -20C. The peak product temperature must be a sufficient amount 
cooler than the collapse temperature, which is the temperature at which the product cake 
will crack and collapse, rendering it useless. At the collapse temperature the actual drug 
will most likely still be functional and maintain its desired physical properties. At slightly 
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higher temperatures it is very possible that the active pharmaceutical ingredient will 
denature, changing the entire identity of the drug. The risk of this occurring is far too 
dangerous, thus the collapse temperature is used as a benchmark rather than the 
temperature at which denaturation occurs.  By using a peak product temperature 
constraint that is lower than the collapse temperature, the risk of producing a denatured 
product is essentially eliminated (Ward, 2019).  
22.3 Food and Drug Administration Regulations 
The Food and Drug Administration (FDA) has outlined three important product 
tests that must be run for lyophilized products. Dose uniformity testing includes two 
separate tests: content uniformity and weight variation. In these tests, the potency of the 
dose should be determined by reconstituting the sample and performing an assay without 
knowing the weight. In a separate test, the weight of the sample should be measured, and 
the results of both tests should be correlated with each other. Stability testing is required to 
determine the amount of moisture present in the vials. This test must be performed to 
determine the expiration date of the drug. Worst case scenario results should always be 
shown on the label, i.e. the highest moisture content and therefore earliest expiration date. 
Sterility testing must confirm that the lyophilized product is completely sterile. Lyophilized 
products are typically reconstituted in sterile water for injection before being administered 
intravenously to the patient, so it is of the utmost importance that the lyophilized product 
shows no signs of contamination. Other product inspection tests that should be performed 
include determination of correct volume of cake, cake appearance, and solubility (Office of 
Regulatory Affairs).  
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For fluid bed granulation, the FDA has initiated a particle analytical technology 
initiative. This allows for operators to determine the particle size of the product while the 
operation is running. A few methods have been introduced, which include image analysis, 
near-infrared spectroscopy, acoustic-emission spectroscopy, focused-beam reflectance 
spectroscopy, and spatial-filter velocimetry for real-time granulation (Pharmaceutical 
Technology). These methods are supposed to be more advanced and more efficient than 
traditional methods used to determine particle size, like laser diffraction and sieve analysis.  
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 The process of fluid bed granulation was able to be further optimized. Reducing the 
phase duration and slightly increasing the power requirements for each piece of equipment 
resulted in operational cost savings. The following recommendations have been listed in 
Table 23.1.  
Table 23.1 – Recommended process parameters for fluid bed granulation 
Control Inputs Value 
Inlet Air Flow Rate 2800 
𝑚3
ℎ𝑟
 
Inlet Air Spraying Temperature 55˚C 
Inlet Air Drying Temperature 75˚C 
Humidity  1-20 
𝑘𝑔 𝑤𝑎𝑡𝑒𝑟
𝑘𝑔 𝑎𝑖𝑟
 
End Time 124 (min)  
Binder Spray Rate  900 
𝑔
𝑠
 
 
Further research should be done into the optimization of these inputs. The “black-
box” MATLAB model did not account for any controls. A series of assumptions needed to be 
made in order to complete this project.  
For the lyophilization process, our recommendation is to run the primary drying 
process for both 8R vials and 20 mL vials with a chamber pressure of 30 Pa, an initial 
chamber temperature of -9˚C, and a final chamber temperature of 1˚C. For the 8R vial 
product, the batch size will be 60,000 vials and the process time will be 16.6 hours. For the 
20 mL vial product, the batch size will be 50,000 vials and the process time will be 15.6 
hours. These conditions meet all of the product constraints and equipment constraints 
while decreasing operational cost. The main form of savings in both cases is due to 
decreased process time which reduces the amount of money that is spent on labor.  The 
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batch size for the 20 mL vials also increased by 10,000 from the base case to the new case 
so that fewer batches need to be run every year. 
Similar to the fluid bed granulation process, many assumptions were made in order 
to determine the best operational conditions. Further research must be done to confirm the 
viability of these conditions. 
Based on the proposed conditions, $31,136 and $23,500 in operational annual 
savings were identified for fluid bed granulation and lyophilization respectively. On a per 
batch basis, cost savings were much higher for lyophilization due to lower batch 
requirements. The main cost drivers behind this reduction were process run time in both 
cases along with higher shelf temperatures for lyophilization and lower inlet airflow rate 
for FBG. A sensitivity analysis on the effect of the NPV of these scenarios showed minimal 
further gains in profitability for conditions significantly cheaper than our proposed. 
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Section 26.1 Project Problem Statement 
You are a sub-team of “Future API Manufacturing Excellence” (FAME), a strategy 
group within a major pharmaceutical company, which is focused on developing business 
cases for potential high-impact technologies. You have partnered with another, internal 
group who has come up with a mathematical model of a crucial part of the lyophilization 
process, the ‘primary drying’ step, which allows you to simulate key characteristics, such as 
the drying time and maximum product temperature (a feature related to quality) in silico. 
They have also created a mathematical model of the fluid bed granulation process, which 
allows you to simulate it and get the drying time (note that the spraying time will depend 
on the solution quantity, which is fixed, and the spray rate, which you should optimize) and 
maximum product moisture (which is related to product quality). You will be given access 
to the model and required to stay within the maximum product moisture design space as 
you optimize the granulation. You will be given access to both “black box” models. 
  For lyophilization, your objective is to design a faster and/or cheaper process that 
satisfies all constraints (product quality and equipment capability) for a new compound, 
HAJVANOX, for which the existing process is suspected to be suboptimal. The cost 
calculation obviously should include items such as the energy cost associated with the low 
pressures and temperatures. 
  For fluid bed granulation, your objective is to optimize the granulation of a high-
volume product, Botilioxin. Your goal is to find a global optimum in cost of running the fluid 
bed granulator considering the energy cost of heating and blowing the air, the electricity 
required to pump the spray, the depreciation of the equipment, labor cost, etc. 
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For both processes, the cost estimates should also include things like, labor, 
depreciation of equipment etc. and the outcome should be compared to the current base 
case processes which will be supplied to you. 22 Specifically, you should calculate the 
change in NPV for your design for lyophilization compared to the base case, and for fluid 
bed granulation compared to its base case. If your design involves additional capital 
expenditures beyond the base case design, calculate the incremental IRR on that 
incremental investment. You should also study the sensitivity of the business cases towards 
external factors such as the demand forecast, raw material cost, retail price of the final 
product, etc. 
 
Section 26.2 Code Snippets 
Both simulations were run using “black-box” MATLAB code. A short snippet of code is 
taken from each black-box model and shown below. 
Section 26.2.1 Fluid Bed Granulation Code Snippet 
function standalone_fbg(U, fileName) 
load('FBGUIdata') % load db 
  
%% set up model 
const = varconst(); 
  
% material parameters and props 
mat = product(4); % product is an array of structures stored in FBGUIdata.mat 
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% process ICs and BCs 
proc = ... % some calculations 
  
% equip 
equip = ... % some calculations 
  
% set input matrix 
U_str = U; 
U = str2num(U); %#ok<ST2NM> input comes in as string that needs to be converted first 
  
U(:,2) = ... % change to SI units 
  
%% run model 
[T,LOD] = FBG_main(const, equip, mat, proc, U); 
  
%% extract outputs 
% maxLOD  
[maxLOD, I] = max(LOD); 
maxLOD_time = T(I); 
  
% end of process LOD 
endLOD = LOD(end); 
endLOD_time = T(end); 
  
% output cell 
A = {U_str, maxLOD_time/60, maxLOD*100, endLOD_time/60, endLOD * 100}; 
  
%% write 
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if nargin < 2 || isempty(fileName) 
    % create a new file 
    fileName = ['fbgOutput_',char(datetime('now','format','ddMMyy_HHmmss')),'.csv']; 
    initiateOutputFile(fileName) % create file and add headers 
     
else 
     
    if strcmpi(fileName(end-3:end),'.csv') 
        if ~exist(fileName,'file') 
            % file doesn't exist yet, so we must initiate it 
            initiateOutputFile(fileName) 
        end 
    else 
        error('standalone_lyo:fileNameNotCsv',... 
            'Output must be written to .csv file.'); 
    end 
end 
  
fid = fopen( fileName, 'a' ); 
fprintf( fid, '%s,%d,%d,%d,%d\n', A{:} ); 
fclose( fid ); 
 
Section 26.2.2 Lyophilization Code Snippet 
 
function standalone_lyo(U, vialGroup, vialType, fileName) 
  
load('models') % load class instances lyo_model1 and lyo_model2 
  
%% set up model 
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% vial type 
if ~ismember(vialType,{'8R','20ml'}) 
 error('standalone_lyo:invalidVialType',... 
         'Input vialGroup must be one of the following: ''8R'', ''20ml''.'); 
end 
  
switch vialType 
 case {'8R'} 
     L = lyo_model1; % this class instance contains constants and parameters associated 
with 8R vials 
 case {'20ml'} 
     L = lyo_model2; % this class instance contains constants and parameters associated 
with 20ml vials 
end 
  
% set input matrix in class instance 
L.procMat.U = str2num(U); %#ok<ST2NM> input comes in as string that needs to be 
converted first 
  
%% run model 
if ~ismember(vialGroup,{'center','corner','edge'}) 
 error('standalone_lyo:invalidVialGroup',... 
         'Input vialGroup must be one of the following: ''center'', ''corner'', ''edge''.'); 
end 
L.runPrimary(vialGroup); % vialGroup must be \in {‘center’,’corner’,’edge’} 
  
%% extract outputs 
% drying time 
Idry = find(abs(L.output.(vialGroup).X(:,2)-100)<0.1,1,'first'); % >=99.9% of water 
removed is considered dry 
if ~isempty(Idry) 
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 tdry = L.output.(vialGroup).time(Idry); 
else 
 tdry = inf; % no dry condition reached within time period 
 Idry = size(L.output.(vialGroup).X,1); 
end 
  
% peak product temperature 
Tp = L.output.(vialGroup).X(1:Idry,1); % only check during active drying phase 
maxTp = max(Tp); 
  
% peak sublimation rate for one vial 
SR = ... % calculating sublimation rate at each time point 
maxSR = max(SR); 
  
% output cell 
A = {U, vialGroup, vialType, tdry, maxTp, maxSR}; 
  
%% write 
if nargin < 4 || isempty(fileName) 
 % create a new file with default filename 
 fileName = ['lyoOutput_',char(datetime('now','format','ddMMyy_HHmmss')),'.csv']; 
  
 initiateOutputFile(fileName) % create file and add headers 
  
else 
  
 if strcmpi(fileName(end-3:end),'.csv') 
     if ~exist(fileName,'file') 
         % file doesn't exist yet, so we must initiate it 
 142 
         initiateOutputFile(fileName) 
     end 
 else 
     error('standalone_lyo:fileNameNotCsv',... 
         'Output must be written to .csv file.'); 
 end 
end 
  
% append to file 
fid = fopen( fileName, 'a' ); 
fprintf( fid, '%s,%s,%s,%d,%d,%d\n', A{:} ); 
fclose( fid ); 
 
Section 26.3 Equipment Design Calculations 
Section 26.3.1. Fluid Bed Granulation Equipment Design Equations  
All of the equations noted in this section were pulled from the Product and Process Design 
Principles textbook (Seider, Warren, et al. Product and Process Design Principles: Synthesis, 
Analysis, and Evaluation). 
 
Heat Exchanger/Condenser 
All equations in this section were used to size and cost the heat exchanger, HX-01, and the 
condenser, CD-01.  
These two equations were used to determine the amount of heat required from the steam 
to heat the ambient air entering the process  
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?̇?𝑖𝑛 = ?̇?𝑜𝑢𝑡 
?̇? = ?̇?𝐶𝑝𝑇 
 
The log mean temperature was used to determine the overall heat transfer coefficient, U, 
and the area for heat transfer, A. 
Tlm =
(𝑇1 − 𝑇2)
𝑙𝑛
𝑇1
𝑇2
 
 
 
This equation was used to determine the overall area for heat transfer within the HX-01 
unit.  
 
𝐴 =
?̇?
𝑈 ∗ Tlm ∗ 𝐹𝑇{𝑅, 𝑆}
 
 
The R and S values were calculated to help determine the efficiency of the heat exchanger. 
These values are based off of the inlet and outlet temperatures of the steam and ambient 
air. These values go into the FT  value stated above. 
𝑅 =
𝑇ℎ𝑜𝑡 𝑖𝑛 − 𝑇ℎ𝑜𝑡 𝑜𝑢𝑡
𝑇𝑐𝑜𝑙𝑑 𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑙𝑑 𝑖𝑛
 
 
𝑆 =
𝑇𝑐𝑜𝑙𝑑 𝑜𝑢𝑡 − 𝑇𝑐𝑜𝑙𝑑 𝑖𝑛
𝑇ℎ𝑜𝑡 𝑖𝑛 − 𝑇𝑐𝑜𝑙𝑑 𝑖𝑛
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This equation was used to determine the cross-sectional area of the tubes of the heat 
exchanger. This value depends on the density of the air, velocity of the air, and the mass 
flow rate.  
𝐴𝑐𝑖 =
𝑚𝑖

𝑖
𝑢𝑖
 
This equation was used to determine the number of tubes required inside the heat 
exchanger. It was determined that the HX did not require any more than one tube.  
𝑁𝑡 =
4𝐴𝑐𝑖
𝐷𝑖
2  
Area of the tubes required. 
𝐴𝑡 = 𝐷𝑖𝐿 
Number of passes needed for the HX. Only one pass was needed.  
𝑁𝑝 =
𝐴𝑖
𝐴𝑡𝑁𝑡
 
This equation was used to calculate the base cost for the heat exchanger. This base cost is 
based off of the area of heat transfer required.  
𝐶𝐵 = 𝑒
11.4185−0.9228∗ln(𝐴)+0.09861(ln (𝐴)2) 
𝐶𝐵(𝐻𝑋−01) = $1,418,753.60 
𝐶𝐵(𝐶𝐷−01) = $12,006,523.71 
This equation is used to determine the purchase cost of the heat exchanger. It is based off of 
the base cost, 𝐶𝐵, and three other variables. These three other variables originate from the 
length of the HX, the material of construction, and the pressure it operates at. All of the 
multipliers used to calculate the cost of purchase were the same for the heat exchanger and 
condenser used in this process.  
𝐶𝑃 = 𝐶𝐵𝐹𝑀𝐹𝐿𝐹𝑃 
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𝐶𝑃(𝐻𝑋−01_ = $5,776,320.53 
𝐶𝑃(𝐶𝐷−01) = $48,040,246.57 
FM  is based off of two constants, a and b. These constants correspond to the material of 
construction for the heat exchanger. The material of construction was stainless steel for the 
shell and the tube side. The constants used are listed below.  
𝐹𝑀 = 𝑎 + (
𝐴
100
)𝑏 
𝑎 = 2.7 
𝑏 = 0.07 
 
 
The FM multiplier used is listed below.  
𝐹𝑀 = 3.31 
Fp is based off of the pressures that the heat exchanger operates at. Both the heat 
exchanger and condenser for this process operated at a pressure of P=14.7 psig.  
𝐹𝑃 = 0.9803 + 0.018 (
𝑃
100
) + 0.0017(
𝑃
100
)2 
The FP multiplier is listed below.  
𝐹𝑃 = 0.98 
The FL multiplier is based off the length of the heat exchanger. The value listed below 
corresponds to a tube length of 8ft. This is the smallest length that could be used in order to 
size the heat exchanger. It was recognized that due to the size of this process, the type of 
heat exchanger needed would be much smaller than this. Therefore, the smallest value 
available was used.  
𝐹𝐿 = 1.25 
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Heater 
This equation was used to determine the heat required to heat up water to steam.  
?̇? = ?̇?𝐶𝑝𝑇 
This equation was used to calculate the amount of heat needed to heat up 10˚C water to 
140˚C steam. This includes the Heat of Vaporization needed in order for water to turn to 
steam. The value of 𝐻𝑣𝑎𝑝 was found to be 40.66 kJ/mol.  
 
?̇?(
𝑘𝐽
𝑚𝑜𝑙
) = ∫ 𝐶𝑝(𝐻2𝑜(𝑙))𝑑𝑇
100˚𝐶
10˚𝐶
+ 𝐻𝑣𝑎𝑝 + ∫ 𝐶𝑝(𝐻2𝑂(𝑔))𝑑𝑇
100˚𝐶
10˚𝐶
 
?̇? = 44.42(
𝑘𝐽
𝑚𝑜𝑙
) 
 
The power that was required from the heater was calculated using this equation. The mass 
flow rate of the water is multiplied by the heat required for the process. This gives the total 
power required in kJ/s.  
𝑃𝑜𝑤𝑒𝑟(
𝑘𝐽
𝑠
) = ?̇??̇? 
𝑃𝑜𝑤𝑒𝑟 (
𝑘𝐽
𝑠
) = 44.42(
𝑘𝐽
𝑚𝑜𝑙
) ∗ 25.79 (
𝑚𝑜𝑙
𝑠
) 
𝑃𝑜𝑤𝑒𝑟 = 1145.8 (
𝑘𝐽
𝑠
) 
 
 
Fan 
In order to calculate the power required from the fan, the pressure head and head in. H2O 
needed to be calculated. Calculating these values help determine the multipliers that 
required for the purchase cost of the fan. All these equations were pulled from  
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Equation used to calculate the pressure head. It was assumed the fan operated at pressures 
slightly below atmospheric.  
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐻𝑒𝑎𝑑 =
(
780 − 𝑃
760 ) ∗ 14.7 ∗ 144
. 0644
 
 
Equation used to determine the Head in. H2O required for this process.  
𝐻𝑒𝑎𝑑 𝑖𝑛. 𝐻2𝑂 =
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐻𝑒𝑎𝑑
17.23
∗ .1924 
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 𝐻𝑒𝑎𝑑 = 19.31 (𝑖𝑛. 𝐻2𝑂) 
 
 
This Q is the flow rate of air required for the process.  
𝑄 = 4927 
𝑓𝑡3
𝑚𝑖𝑛
= 2800
𝑚3
ℎ𝑟
 
 
This FM multiplier corresponds with the material of construction. For stainless steel, the 
multiplier is listed below.  
𝐹𝑀 = 2.5 
The value of FH corresponds to Head (in. H2O) calculated above. Since total Head was 
determined to be 19.31, the FH value is 1.45.  
𝐹𝐻 = 1.45 
The base cost multiplier is based on the flow rate of air required for the process, which is 
2800 (m3/hr).   
𝐶𝐵 = 𝑒
11.4152−1.3805∗ln(𝑄)+0.1139(ln (𝑄)2) 
𝐶𝐵 = $2,728.80 
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The purchase cost of the fan is the multiplication of all the multipliers listed above.  
 
𝐶𝑃 = 𝐶𝐵𝐹𝑀𝐹𝐻 
𝐶𝑃 = $9.891.90 
 
The power required for this process was calculated using the equation below. It is based off 
of the flow rate (Q), Head (H), motor efficiency (nm), and fan efficiency (nf). It was assumed 
that the fan efficiency was 0.6 and the motor efficiency was 0.9.  
𝑃𝑜𝑤𝑒𝑟 (𝑘𝑊) =
𝑄𝐻
6350𝑛𝑓𝑛𝑚
∗ 0.7457 
𝑃𝑜𝑤𝑒𝑟 = 25.58 (𝑘𝑊) 
 
Pump 
The pump required for this process is a peristaltic pump. There were no equipment 
calculations available in order to size or cost this piece of equipment. As recommend by the 
project author, research was done on a series of peristaltic pumps typically used in 
pharmaceutical processes. It was determined that the best option was one manufactured 
by Verdor Flex. The pump chosen operates at atmospheric pressures and has a maximum 
flow rate of 1.7 (L/min). For the fluid bed granulation process, the flow rate of binder 
required was 0.89 (L/min). The pump chosen falls within the specs needed for the process. 
The estimated cost for this type of pump is around $300-$500. Additional cost for this 
pump would be incurred through the replacement of tubes needed for the pump.  
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Filters  
Similar to the pump needed for the process, there does not exists a sizing or costing 
resources for the filters required for the process. A possible vendor found was Advanced 
Filtration Concepts. They manufacture and sell filters typically used for processes that 
require the highest standard of sterilization. A HV HEPA Filter was determined to be the 
best option for this process. Its specs fall within the particle size of what needs to be 
removed from the air in addition to keeping the product inside the process. Their smallest 
filter with dimensions of 12’’x24’’x11.5’’ would be the best option for this process.  
  
Section 26.3.2 Lyophilization Equipment Design Equations  
Heater Design Calculations 
Because the process is operating at extremely low pressures, it is expected that any heat 
transfer due to convection will be negligible. Compared to heat due to conduction and the 
heat of sublimation of ice, the heat of radiation was also negligible. The heat duty of the 
heater was calculated by determining the amount of energy required to change the 
temperature of the stainless steel shelves, the glass vials, and the product within the vial as 
well as adding the heat required to sublimate the ice. 
The heat required to increase the temperature of the shelves in the chamber is given by: 
 
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠 = 𝑚 ∗ 𝐶𝑝,𝑠𝑡𝑒𝑒𝑙 ∗ ∆𝑇 
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Assuming 10 large stainless steel shelves with a thickness of 5 mm and dimensions of 1550 
mm x 1600 mm, the total shelf mass can be calculated as follows: 
 
𝑚𝑠ℎ𝑒𝑙𝑣𝑒𝑠(𝑘𝑔) =  10 ∗ 1.55 𝑚 ∗ 1.6 𝑚 ∗ 0.005 𝑚 ∗ 2 ∗ 7900
𝑘𝑔
𝑚3
= 1959.2 𝑘𝑔 
 
The temperature change from -45˚C (228 K) to T1: 
 
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,1(𝑘𝐽) = 1959.2 𝑘𝑔 ∗ 439.5
𝐽
𝑘𝑔 ∗ 𝐾
∗ (𝑇1 − 228 𝐾) ∗ 0.001
𝑘𝐽
𝐽
 
 
The temperature change occurs over a period of 1.5 hours so power can be calculated as 
follows: 
 
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,1(𝑘𝑊) =
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,1(𝑘𝐽)
1.5 ℎ𝑟 ∗ (3600
𝑠𝑒𝑐
ℎ𝑟
)
 
 
The temperature change from T1 to T2: 
 
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,2(𝑘𝐽) = 1959.2 𝑘𝑔 ∗ 439.5
𝐽
𝑘𝑔 ∗ 𝐾
∗ (𝑇2 − 𝑇1 𝐾) ∗ 0.001
𝑘𝐽
𝐽
 
 
The temperature change occurs over a period of 1.5 hours so power can be calculated as 
follows: 
 
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,2(𝑘𝑊) =
𝑄𝑠ℎ𝑒𝑙𝑣𝑒𝑠,2(𝑘𝐽)
1.5 ℎ𝑟 ∗ (3600
𝑠𝑒𝑐
ℎ𝑟
)
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Table 26.3.2.1. Heat duty for shelves. 
 8R Vial 20 mL Vial 
Base Case 30,137 kJ 30,137 kJ 
New Case 39,609 kJ 39,609 kJ 
 
Table 26.3.2.2. Power for shelf heating. 
 8R Vial 20 mL Vial 
Base Case 5.58 kW 5.58 kW 
New Case 7.34 kW 7.34 kW 
 
𝑄𝑣𝑖𝑎𝑙𝑠 = 𝑁 ∗ 𝑚 ∗ 𝐶𝑝,𝑏𝑜𝑟𝑜𝑠𝑖𝑙𝑖𝑐𝑎𝑡𝑒 ∗ ∆𝑇 
Where N= number vials 
The mass, volume, and heat capacity of both vial types are given by the Schott 
Pharmaceutical Packaging Manual (Schott): 
Schott borosilicate 8R vial 
Mass: 8.7 g 
Volume: 10 mL 
Cp= 830 J/kg*K 
 
Schott borosilicate 20 mL vial 
Mass: 16.2 g 
Volume: 20 mL 
Cp= 830 J/kg*K 
 
Similarly to the shelves, the temperature change from -45˚C (228 K) to T1: 
 
𝑄𝑣𝑖𝑎𝑙𝑠,1(𝑘𝐽) = 𝑁 ∗ 𝑚𝑣𝑖𝑎𝑙(𝑘𝑔) ∗ 830
𝐽
𝑘𝑔 ∗ 𝐾
∗ (𝑇1 − 228 𝐾) ∗ 0.001
𝑘𝐽
𝐽
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The temperature change occurs over a period of 1.5 hours so power can be calculated as 
follows: 
 
𝑄𝑣𝑖𝑎𝑙𝑠,1(𝑘𝑊) =
𝑄𝑣𝑖𝑎𝑙𝑠,1(𝑘𝐽)
1.5 ℎ𝑟 ∗ (3600
𝑠𝑒𝑐
ℎ𝑟
)
 
 
The temperature change from T1 to T2: 
 
𝑄𝑣𝑖𝑎𝑙𝑠,2(𝑘𝐽) = 𝑁 ∗ 𝑚𝑣𝑖𝑎𝑙(𝑘𝑔) ∗ 830
𝐽
𝑘𝑔 ∗ 𝐾
∗ (𝑇2 − 𝑇1 𝐾) ∗ 0.001
𝑘𝐽
𝐽
 
 
The temperature change occurs over a period of 1.5 hours so power can be calculated as 
follows: 
𝑄𝑣𝑖𝑎𝑙𝑠,2(𝑘𝑊) =
𝑄𝑣𝑖𝑎𝑙𝑠,2(𝑘𝐽)
1.5 ℎ𝑟 ∗ (3600
𝑠𝑒𝑐
ℎ𝑟
)
 
 
Table 26.3.2.3. Heat duty for vials. 
 8R Vial 20 mL Vial 
Base Case 15,164 kJ 18,824 kJ 
New Case 19,930 kJ 30,926 kJ 
 
 
Table 26.3.2.4. Power for vial heating. 
 8R Vial 20 mL Vial 
Base Case 2.81 kW 3.49 kW 
New Case 3.69 kW 5.73 kW 
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At each different pressure, the sublimation temperature, Tsub (K), was calculated using the 
following equation 
𝑃𝑖𝑐𝑒 (𝑃𝑎) = exp (9.550426 −
5723.265
𝑇𝑠𝑢𝑏
+ 3.53068 ∗ ln(𝑇𝑠𝑢𝑏) − 0.00728332𝑇𝑠𝑢𝑏) 
 
Sublimation temperatures were calculated for the following pressures: 
Table 26.3.2.5. Ice sublimation temperatures. 
P (Pa) Tsub (K) 
10 230.95844 
20 237.13047 
26 239.55344 
30 240.89595 
40 243.64092 
 
The energy required to heat the ice from -45˚C (228 K) to the sublimation temperature is 
given by: 
 
𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) =  
1 𝑚𝑜𝑙
18.02 𝑔
∗ 1000
𝑔
𝑘𝑔
∗ ∫ 𝐶𝑝,𝑖𝑐𝑒𝑑𝑇
𝑇𝑠𝑢𝑏
228 𝐾
 
 
Where the heat capacity of ice is given by: 
 
𝐶𝑝,𝑖𝑐𝑒(
𝐽
𝑚𝑜𝑙 ∗ 𝐾
) = −2.0572 + 0.14644𝑇 + 0.06163𝑇𝑒(−(
𝑇
125.1
)2) 
 
The heat of sublimation is given by: 
 
𝐻𝑠𝑢𝑏(
𝐽
𝑚𝑜𝑙
) = 46782.5 + 35.8925𝑇 − 0.07414𝑇2 + 541.5𝑒(−(
𝑇
123.75
)2) 
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𝐻𝑠𝑢𝑏 (
𝐽
𝑘𝑔
) =
1 𝑚𝑜𝑙
18.02 𝑔
∗ 1000
𝑔
𝑘𝑔
∗ 𝐻𝑠𝑢𝑏(
𝐽
𝑚𝑜𝑙
) 
 
The energy required to heat the vapor from the sublimation temperature (Tsub) to T2 is 
given by:  
 
𝑄𝑣𝑎𝑝𝑜𝑟 (
𝐽
𝑘𝑔
) =
1 𝑚𝑜𝑙
18.02 𝑔
∗ 1000
𝑔
𝑘𝑔
∗ ∫ 𝐶𝑝,𝑣𝑎𝑝𝑜𝑟𝑑𝑇
𝑇2
𝑇𝑠𝑢𝑏
 
 
Where the heat capacity of vapor is given by 1: 
 
𝐶𝑝,𝑣𝑎𝑝𝑜𝑟(
𝐽
𝑚𝑜𝑙 ∗ 𝐾
) = −35.319 + 0.14457𝑇 + 0.06155𝑇𝑒(−(
𝑇
129.85
)2) 
 
The total heat required for the ice is given by: 
 
𝑄𝑖𝑐𝑒(
𝐽
𝑘𝑔
) = 𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) + 𝐻𝑠𝑢𝑏(𝑇𝑠𝑢𝑏) +  𝑄𝑣𝑎𝑝𝑜𝑟 (
𝐽
𝑘𝑔
) 
 
Given that the vials contain 88-95% water before freeze drying, it is assumed that each vial 
contains 91.5% water. It is also assumed that all water will be sublimated off during 
primary drying. 
For the 8R vial product, the amount of water present in each vial is given by: 
 
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 (𝑘𝑔) = 10 𝑚𝐿 ∗ 0.915 ∗ 1
𝑔
𝑚𝐿
∗ 0.001
𝑘𝑔
𝑔
= 0.0087 𝑘𝑔 
 
To get the total amount of water that is being sublimated, multiply the mass of water per 
vial by N, the total number of vials. 
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𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) = 𝑁 ∗ 0.0087 𝑘𝑔 
 
For the 20 mL vial product, the amount of water present in each vial is given by: 
 
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 𝑝𝑒𝑟 𝑣𝑖𝑎𝑙 (𝑘𝑔) = 20 𝑚𝐿 ∗ 0.915 ∗ 1
𝑔
𝑚𝐿
∗ 0.001
𝑘𝑔
𝑔
= 0.0183 𝑘𝑔 
 
To get the total amount of water that is being sublimated, multiply the mass of water per 
vial by N, the total number of vials. 
 
𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) = 𝑁 ∗ 0.0183 𝑘𝑔 
 
The heat duty for sublimation can be calculated by: 
 
𝐻𝑒𝑎𝑡 𝑑𝑢𝑡𝑦 𝑜𝑓 𝑖𝑐𝑒 (𝑘𝐽) =  𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) ∗ 𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) ∗ 0.001
𝐽
𝑘𝐽
 
 
Table 26.3.2.6. Heat duty for ice heating and sublimation 
 8R Vial 20 mL Vial 
Base Case 1.57*106 kJ 1.05*106 kJ 
New Case 1.57*106 kJ 1.31*106 kJ 
 
To get the average rate of sublimation, divide the total mass of water by the total process 
time. 
 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑅𝑎𝑡𝑒 𝑜𝑓 𝑆𝑢𝑏𝑙𝑖𝑚𝑎𝑡𝑖𝑜𝑛 (
𝑘𝑔
ℎ𝑟
) =
𝑡𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔)
𝑡𝑜𝑡𝑎𝑙 𝑝𝑟𝑜𝑐𝑒𝑠𝑠 𝑡𝑖𝑚𝑒 (ℎ𝑟)
 
 
To get the total power used to heat and sublimate the ice: 
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𝑄𝑖𝑐𝑒(𝑘𝑊) = 𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) ∗ 𝐴𝑣𝑔 𝑆𝑢𝑏 𝑅𝑎𝑡𝑒 (
𝑘𝑔
ℎ𝑟
) ∗ 0.001
𝐽
𝑘𝐽
 
 
Table 26.3.2.7. Power for ice heating and sublimation. 
 8R Vial 20 mL Vial 
Base Case 17.3 kW 13.3 kW 
New Case 26.3 kW 23.3 kW 
 
In table 26.3.2.8, all of the previously calculated heat duties are added together to get the 
total heat duty required by the electric heater. 
Table 26.3.2.8. Total required heat duty for electric heater. 
 8R Vial 20 mL Vial 
Base Case 1.62*106 kJ 1.10*106 kJ 
New Case 1.63*106 kJ 1.38*106 kJ 
 
In table 26.3.2.9, the previously calculated powers are added together to get the total 
power required by the electric heater. 
Table 26.3.2.9. Total required power for electric heater. 
 8R Vial 20 mL Vial 
Base Case 25.7 kW 22.3 kW 
New Case 37.3 kW 36.4 kW 
 
The heater has an efficiency of 90%. Table 26.3.2.10 shows the total required power for the 
electric heater after taking the efficiency factor into account. 
Table 26.3.2.10 Total required power with 90% efficiency. 
 8R Vial 20 mL Vial 
Base Case 28.6 kW 24.8 kW 
New Case 41.4 kW 40.4 kW 
 
Condenser Design Calculations 
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The condenser is a stainless steel cooling coil with cold silicon oil at -55˚C flowing through 
it. The silicon oil must be able to absorb heat from the stainless steel condenser surface. 
The condenser will mainly absorb heat through deposition of water vapor to ice. Radiation 
and convection are negligible in comparison to the heat duty required by ice deposition. 
The condenser must first undergo a temperature change from -45˚C to -55˚C which will 
take approximately 1.5 hours. 
Assuming the condenser uses 1 inch tubing (Seider): 
ID= 0.622 in (0.0158 m) 
OD= 0.84 in (0.0213 m) 
Length= 16.5 m 
 
The volume of the stainless steel condenser is given by 
 
𝑉𝑜𝑙𝑢𝑚𝑒𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟(𝑚
3) = 𝜋 ∗ 16.5 𝑚 ∗ ((
0.0213
2
𝑚)2 − (
0.0158
2
𝑚)2) = 0.00266 𝑚3 
 
𝑀𝑎𝑠𝑠𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟(𝑘𝑔) =  7900
𝑘𝑔
𝑚3
∗ 0.00266 𝑚3 = 21.05 𝑘𝑔 
 
The heat that the condenser must absorb in order to decrease in temperature from -45˚C 
(228 K) to -55˚C (218 K) is given by:  
 
𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 = 𝑚𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 ∗ 𝐶𝑝,𝑠𝑡𝑒𝑒𝑙 ∗ (218 − 228 𝐾) 
 
𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 (𝑘𝐽) = 𝑚𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟 ∗ 439.5
𝐽
𝑘𝑔 ∗ 𝐾
∗ (218 − 228 𝐾) ∗ 0.001
𝐽
𝑘𝐽
= −92.5 𝑘𝐽 
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The temperature change will occur over a period of 1.5 hours so the power that must be 
removed by the refrigeration system is given by: 
𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟(𝑘𝑊) =
𝑄𝑐𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑟(𝑘𝐽)
1.5 ℎ𝑟 ∗ (3600
𝑠𝑒𝑐
ℎ𝑟
)
= −0.0171 𝑘𝑊 
 
The heat required to cool the vapor to the deposition temperature (Tdep) is given by: 
 
𝑄𝑣𝑎𝑝𝑜𝑟 (
𝐽
𝑘𝑔
) =
1 𝑚𝑜𝑙
18.02 𝑔
∗ 1000
𝑔
𝑘𝑔
∗  ∫ 𝐶𝑝,𝑣𝑎𝑝𝑜𝑟𝑑𝑇
𝑇𝑑𝑒𝑝
𝑇2
 
Where: 
𝐶𝑝,𝑣𝑎𝑝𝑜𝑟 = −35.319 + 0.14457𝑇 + 0.06155𝑇𝑒
(−(
𝑇
129.85
)2) 
 
The heat given off from deposition is given by: 
 
𝐻𝑑𝑒𝑝 (
𝐽
𝑚𝑜𝑙
) = −(46782.5 + 35.8925𝑇 − 0.07414𝑇2 + 541.5𝑒(−(
𝑇
123.75
)2)) 
 
𝐻𝑑𝑒𝑝 (
𝐽
𝑘𝑔
) =
1 𝑚𝑜𝑙
18.02 𝑔
∗ 1000
𝑔
𝑘𝑔
∗ 𝐻𝑑𝑒𝑝(
𝐽
𝑚𝑜𝑙
) 
 
The heat that must be removed to decrease the temperature of the ice from Tsub to -45˚C 
(228 K) is given by: 
 
𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) =  
1 𝑚𝑜𝑙
18.02 𝑔
∗ 1000
𝑔
𝑘𝑔
∗ ∫ 𝐶𝑝,𝑖𝑐𝑒𝑑𝑇
228 𝐾
𝑇𝑑𝑒𝑝
 
Where: 
𝐶𝑝,𝑖𝑐𝑒 = −2.0572 + 0.14644𝑇 + 0.06163𝑇𝑒
(−(
𝑇
125.1
)2) 
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The total heat that must be removed to decrease the temperature of the vapor, depose the 
vapor, and decrease the temperature of the ice is given by: 
𝑄𝑖𝑐𝑒(
𝐽
𝑘𝑔
) = 𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) + 𝐻𝑑𝑒𝑝(𝑇𝑑𝑒𝑝) +  𝑄𝑣𝑎𝑝𝑜𝑟 (
𝐽
𝑘𝑔
) 
 
The heat duty required to depose the ice can be calculated as follows: 
𝐻𝑒𝑎𝑡 𝑑𝑢𝑡𝑦 𝑜𝑓 𝑖𝑐𝑒 (𝑘𝐽) =  𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) ∗ 𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑤𝑎𝑡𝑒𝑟 (𝑘𝑔) ∗ 0.001
𝐽
𝑘𝐽
 
Table 26.3.2.11. Heat duty for ice cooling and sublimation. 
 8R Vial 20 mL Vial 
Base Case -1.58*106 kJ -1.05*106 kJ 
New Case -1.58*106 kJ -5.28*105 kJ 
 
The average rate of deposition must be the same as the average rate of sublimation, so that 
the required power of refrigeration is given by: 
𝑄𝑖𝑐𝑒(𝑘𝑊) = 𝑄𝑖𝑐𝑒 (
𝐽
𝑘𝑔
) ∗ 𝐴𝑣𝑔 𝑆𝑢𝑏 𝑅𝑎𝑡𝑒 (
𝑘𝑔
ℎ𝑟
) ∗ 0.001
𝐽
𝑘𝐽
 
 
Table 26.3.2.12. Power for ice cooling and sublimation. 
 8R Vial 20 mL Vial 
Base Case -17.4 kW -13.4 kW 
New Case -26.5 kW -8.83 kW 
 
Combining these results with the heat duty and power requirements for the condenser 
above, we can calculate total heat duty and power requirements. 
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Table 26.3.2.13. Total heat duty required by condenser. 
 8R Vial 20 mL Vial 
Base Case -1.58*106 kJ -1.05*106 kJ 
New Case -1.58*106 kJ -5.28*105 kJ 
 
Table 26.3.2.14. Total power required by condenser. 
 8R Vial 20 mL Vial 
Base Case -17.4 kW -13.4 kW 
New Case -26.5 kW -8.84 kW 
 
The refrigeration system has an efficiency of 80%. Table 26.3.2.15 shows the total required 
power for the condenser after taking the efficiency factor into account. 
Table 26.3.2.15. Total power required by condenser with 80% efficiency factor.  
 8R Vial 20 mL Vial 
Base Case -21.75 kW -16.75 kW 
New Case -33.13 kW -11.1 kW 
 
 
 
Vacuum Pump Design Calculations 
The vacuum pump is used to decrease the pressure of the lyophilization chamber from 
atmospheric pressure to the extremely low pressures required by lyophilization. The 
pressure is varied from 10 to 40 Pa in this project. The pump must then maintain the lower 
pressure for the duration of primary drying. The price of the vacuum pump will vary 
significantly depending on the operational pressure, so this is the one piece of equipment in 
lyophilization that will be costed. The price of the vacuum pump is dependent on S 
(ft3/min), the flow at suction. For a long process such as primary drying in lyophilization, 
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the flow rate at suction that is handled by the vacuum system is based on the air leakage 
into the equipment. 
The Heat Exchange Institute provides the following equation to estimate air leakage rate 
based on operation pressure and chamber volume. 
𝑊 (
𝑙𝑏
ℎ𝑟
) = 5 + {0.0298 + 0.03088[ln(𝑃)] − 0.0005733 ∗ [ln(𝑃)]2}𝑉0.66 
Where: 
𝑊[=]
𝑙𝑏
ℎ𝑟
  
𝑃[=]𝑡𝑜𝑟𝑟 
𝑉[=]𝑓𝑡3 
 
It is known that the volume of the chamber is 17,000 L or approximately 600 ft3. This 
equation is only applicable for pressures above 1 torr. Because the operational pressures 
are lower than 1 torr, this equation was converted to a polynomial equation and 
extrapolated to include pressures below 1 torr. The polynomial equation is given as 
follows: 
𝑊 = −0.008𝑃4 + 0.0611𝑃3 − 0.1384𝑃2 + 0.2459𝑃 + 4.9143 
 
This equation is used to determine the air leakage rate at different pressures. The flow at 
suction, S, is determined: 
 
𝑆 =
𝑊
𝑃
 
Where 
𝑆[=] 
𝑓𝑡3
𝑚𝑖𝑛
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The cost is based on an equation from the textbook: 
 
𝐶𝑝 = 10,875 ∗ 𝑆
0.38 
 
The vacuum pump will be made of stainless steel, which adds a cost multiplier of 2, so the 
total purchase cost of the vacuum is given by: 
𝐶𝑝 = 2 ∗ 10,875 ∗ 𝑆
0.38 
 
The bare module factor for a pump is 3.30 and the investment site factor for a country in 
Western Europe is 1.20. Thus the bare module cost of the vacuum pump is given by: 
𝐶𝐵𝑀 = 3.30 ∗ 1.20 ∗ 2 ∗ 10,875 ∗ 𝑆
0.38 
 
Table 26.3.2.15. Bare module vacuum pump cost. 
 8R Vial 20 mL Vial 
Base Case $284,397 $284,397 
New Case $272,406 $272,406 
 
The operational costs of the vacuum pump can be calculated using the following equation 
with inputs of W (gas flow rate), Pa (suction pressure), Pd (discharge pressure), and 𝜂𝑑 , the 
adiabatic thermal efficiency of dry vacuum pumps.  
𝑃 =
𝑊 ∗ ((
𝑃𝑑
𝑃𝑎
)
0.286
− 1)
12 ∗ 𝜂𝑑
 
Where: 
𝑃[=] ℎ𝑝 
𝑊[=]
𝑙𝑏
ℎ𝑟
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𝑃𝑑  𝑎𝑛𝑑 𝑃𝑎  [=]𝑡𝑜𝑟𝑟 
 
Table 26.3.2.16. Power required by vacuum pump. 
 8R Vial 20 mL Vial 
Base Case 5.69 hp 5.69 hp 
New Case 5.44 hp 5.44 hp 
 
Section 26.4 Fluid Bed Granulation Simulation Results 
Below are the simulations that were run throughout the duration of this project.  
With the help of the abbreviated full-factorial method mentioned in Section 13, these were 
the first simulations run. These results helped narrow down which type of inputs we 
should start with.  
Sim 
# Input Matrix 
Max LOD Time 
[min] 
Max LOD 
[%] 
End Time 
[min] 
End LOD 
[%] 
1 
[0 46 6.2 2500 1000;100 75 6.2 2500 0;175 
NaN NaN NaN NaN] 100 14.90 175 2.93 
2 
[0 58 6.2 2500 800;100 75 6.2 2500 0;175 
NaN NaN NaN NaN] 100 8.26 175 0.09 
3 
[0 46 6.2 2500 800;100 75 6.2 2500 0;175 
NaN NaN NaN NaN] 100 11.00 175 0.58 
4 
[0 58 6.2 2500 1000;100 75 6.2 2500 0;175 
NaN NaN NaN NaN] 100 12.30 175 1.06 
 
The only inputs changed in this set of simulations were the inlet air temperature and the 
binder spray rate. Simulations 1,2, and 3 were the ones that had the LOD% values that fell 
closest to the constraints required for the product. Based on these results and 
recommendations from the project author, it was decided that the phase duration for the 
drying step needed to be altered. The next set of simulations were run at a series of ranging 
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drying temperatures—both with high and low inlet temperatures. The binder spray rate 
was kept the same. 
Once it was determined which range of values should be focused on, the rest of the inputs 
needed to be optimized. With a recommendation from the project author, the drying phase 
duration was reduced to see if that had a great effect on the end LOD% values.   
Low Inlet 
Temperatures      
1 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;150 NaN NaN NaN NaN] 100 12.80 150 2.60 
2 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;151 NaN NaN NaN NaN] 100 12.80 151 2.45 
3 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;152 NaN NaN NaN NaN] 100 12.80 152 2.31 
4 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;153 NaN NaN NaN NaN] 100 12.80 153 2.17 
5 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;154 NaN NaN NaN NaN] 100 12.80 154 2.04 
6 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;155 NaN NaN NaN NaN] 100 12.80 155 1.91 
7 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;156 NaN NaN NaN NaN] 100 12.80 156 1.79 
8 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;157 NaN NaN NaN NaN] 100 12.80 157 1.67 
9 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;158 NaN NaN NaN NaN] 100 12.80 158 1.56 
10 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;159 NaN NaN NaN NaN] 100 12.80 159 1.45 
11 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;160 NaN NaN NaN NaN] 100 12.80 160 1.34 
12 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;161 NaN NaN NaN NaN] 100 12.80 161 1.24 
13 
[0 46 6.2 3200 1000;100 75 6.2 3200 
0;162 NaN NaN NaN NaN] 100 12.80 162 1.15 
14 
[0 46 6.2 3200 800;100 75 6.2 3200 0;150 
NaN NaN NaN NaN] 100 8.80 150 0.55 
15 
[0 46 6.2 3200 800;100 75 6.2 3200 0;151 
NaN NaN NaN NaN] 100 8.80 151 0.48 
16 
[0 46 6.2 3200 800;100 75 6.2 3200 0;152 
NaN NaN NaN NaN] 100 8.80 152 0.41 
17 
[0 46 6.2 3200 800;100 75 6.2 3200 0;153 
NaN NaN NaN NaN] 100 8.80 153 0.34 
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18 
[0 46 6.2 3200 800;100 75 6.2 3200 0;154 
NaN NaN NaN NaN] 100 8.80 154 0.28 
19 
[0 46 6.2 3200 800;100 75 6.2 3200 0;155 
NaN NaN NaN NaN] 100 8.80 155 0.21 
20 
[0 46 6.2 3200 800;100 75 6.2 3200 0;156 
NaN NaN NaN NaN] 100 8.80 156 0.15 
21 
[0 46 6.2 3200 800;100 75 6.2 3200 0;157 
NaN NaN NaN NaN] 100 8.80 157 0.10 
22 
[0 46 6.2 3200 800;100 75 6.2 3200 0;158 
NaN NaN NaN NaN] 100 8.80 158 0.09 
23 
[0 46 6.2 3200 800;100 75 6.2 3200 0;159 
NaN NaN NaN NaN] 100 8.80 159 0.09 
24 
[0 46 6.2 3200 800;100 75 6.2 3200 0;160 
NaN NaN NaN NaN] 100 8.80 160 0.09 
25 
[0 46 6.2 3200 800;100 75 6.2 3200 0;161 
NaN NaN NaN NaN] 100 8.80 161 0.09 
26 
[0 46 6.2 3200 800;100 75 6.2 3200 0;162 
NaN NaN NaN NaN] 100 8.80 162 0.09 
High Inlet 
Temperatures       
27 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;150 NaN NaN NaN NaN] 100 9.32 150 0.67 
28 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;151 NaN NaN NaN NaN] 100 9.32 151 0.60 
29 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;152 NaN NaN NaN NaN] 100 9.32 152 0.52 
30 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;153 NaN NaN NaN NaN] 100 9.32 153 0.45 
31 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;154 NaN NaN NaN NaN] 100 9.32 154 0.38 
32 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;155 NaN NaN NaN NaN] 100 9.32 155 0.32 
33 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;156 NaN NaN NaN NaN] 100 9.32 156 0.25 
34 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;157 NaN NaN NaN NaN] 100 9.32 157 0.19 
35 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;158 NaN NaN NaN NaN] 100 9.32 158 0.13 
36 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;159 NaN NaN NaN NaN] 100 9.32 159 0.09 
37 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;160 NaN NaN NaN NaN] 100 9.32 160 0.09 
38 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;161 NaN NaN NaN NaN] 100 9.32 161 0.09 
39 
[0 58 6.2 3200 1000;100 75 6.2 3200 
0;162 NaN NaN NaN NaN] 100 9.32 162 0.09 
40 
[0 58 6.2 3200 800;100 75 6.2 3200 0;150 
NaN NaN NaN NaN] 100 5.57 150 0.09 
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41 
[0 58 6.2 3200 800;100 75 6.2 3200 0;151 
NaN NaN NaN NaN] 100 5.57 151 0.09 
42 
[0 58 6.2 3200 800;100 75 6.2 3200 0;152 
NaN NaN NaN NaN] 100 5.57 152 0.09 
43 
[0 58 6.2 3200 800;100 75 6.2 3200 0;153 
NaN NaN NaN NaN] 100 5.57 153 0.09 
44 
[0 58 6.2 3200 800;100 75 6.2 3200 0;154 
NaN NaN NaN NaN] 100 5.57 154 0.09 
45 
[0 58 6.2 3200 800;100 75 6.2 3200 0;155 
NaN NaN NaN NaN] 100 5.57 155 0.08 
46 
[0 58 6.2 3200 800;100 75 6.2 3200 0;156 
NaN NaN NaN NaN] 100 5.57 156 0.08 
47 
[0 58 6.2 3200 800;100 75 6.2 3200 0;157 
NaN NaN NaN NaN] 100 5.57 157 0.08 
48 
[0 58 6.2 3200 800;100 75 6.2 3200 0;158 
NaN NaN NaN NaN] 100 5.57 158 0.08 
49 
[0 58 6.2 3200 800;100 75 6.2 3200 0;159 
NaN NaN NaN NaN] 100 5.57 159 0.08 
50 
[0 58 6.2 3200 800;100 75 6.2 3200 0;160 
NaN NaN NaN NaN] 100 5.57 160 0.08 
51 
[0 58 6.2 3200 800;100 75 6.2 3200 0;161 
NaN NaN NaN NaN] 100 5.57 161 0.08 
52 
[0 58 6.2 3200 800;100 75 6.2 3200 0;162 
NaN NaN NaN NaN] 100 5.57 162 0.08 
 
After running simulations at drying temperature phases ranging from 150-162 minutes, it 
was found that the product was still too dry for what is required. It was found that a few 
simulations fell within the constraints, so it was decided to lower the phase duration even 
more.  
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Lower Drying 
Temperatures      
53 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;120 NaN NaN NaN NaN] 100 8.80E+00 120 4.66E+00 
54 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;121 NaN NaN NaN NaN] 100 8.80E+00 121 4.44E+00 
55 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;122 NaN NaN NaN NaN] 100 8.80E+00 122 4.23E+00 
56 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;123 NaN NaN NaN NaN] 100 8.80E+00 123 4.02E+00 
57 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;124 NaN NaN NaN NaN] 100 8.80E+00 124 3.82E+00 
58 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;125 NaN NaN NaN NaN] 100 8.80E+00 125 3.63E+00 
59 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;126 NaN NaN NaN NaN] 100 8.80E+00 126 3.44E+00 
60 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;127 NaN NaN NaN NaN] 100 8.80E+00 127 3.25E+00 
61 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;128 NaN NaN NaN NaN] 100 8.80E+00 128 3.07E+00 
62 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;129 NaN NaN NaN NaN] 100 8.80E+00 129 2.90E+00 
63 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;130 NaN NaN NaN NaN] 100 8.80E+00 130 2.74E+00 
64 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;131 NaN NaN NaN NaN] 100 8.80E+00 131 2.58E+00 
65 
[0 46 6.2 3200 800;100 75 6.2 3200 
0;132 NaN NaN NaN NaN] 100 8.80E+00 132 2.43E+00 
 
After running simulations at lower drying temperatures, ranging from 120-132 minutes, it 
was found that a series of these simulations fell within the Max LOD and End LOD% values.  
 
After presenting these findings to the project author, it was found that the inlet air 
temperature chosen for these simulations were too low for the heat exchanger to reach 
equilibrium quickly. In order for the process to run efficiently, the author recommended 
the inlet air spraying temperature should be a maximum of 20˚C from the inlet air drying 
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temperature of 75˚C. Therefore, the inlet air spraying temperature was increased to a value 
of 55˚C.  
The next set of simulations were ones run at an inlet air spray temperature of 55˚C.  
Sim 
# Input Matrix 
Max LOD 
Time [min] 
Max LOD 
[%] 
End Time 
[min] 
End LOD 
[%] 
1 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;120 NaN NaN NaN NaN] 100 8.22E+00 120 3.98E+00 
2 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;122 NaN NaN NaN NaN] 100 8.22E+00 122 3.58E+00 
3 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;124 NaN NaN NaN NaN] 100 8.22E+00 124 3.21E+00 
4 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;126 NaN NaN NaN NaN] 100 8.22E+00 126 2.86E+00 
5 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;128 NaN NaN NaN NaN] 100 8.22E+00 128 2.55E+00 
6 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;130 NaN NaN NaN NaN] 100 8.22E+00 130 2.25E+00 
7 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;132 NaN NaN NaN NaN] 100 8.22E+00 132 1.98E+00 
8 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;134 NaN NaN NaN NaN] 100 8.22E+00 134 1.74E+00 
9 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;136 NaN NaN NaN NaN] 100 8.22E+00 136 1.51E+00 
10 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;138 NaN NaN NaN NaN] 100 8.22E+00 138 1.30E+00 
11 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;140 NaN NaN NaN NaN] 100 8.22E+00 140 1.11E+00 
12 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;142 NaN NaN NaN NaN] 100 8.22E+00 142 9.27E-01 
13 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;144 NaN NaN NaN NaN] 100 8.22E+00 144 7.60E-01 
14 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;146 NaN NaN NaN NaN] 100 8.22E+00 146 6.04E-01 
15 
[0 55 6.2 3200 900;100 75 6.2 3200 
0;148 NaN NaN NaN NaN] 100 8.22E+00 148 4.58E-01 
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Some of the simulations run at 55˚C were found to fall within the constraints required for 
the process, simulations 3-6. Based on these results, the sweet spot for the process.  
 
The next step was determining if altering the humidity values would affect the LOD values. 
The black-box modal does not account for any control for the condenser. Additionally, the 
humidity of the ambient air differs from day to day. As told by the project author, the 
condenser lets any air humidity over the value of 7.6(kg H2O/kg air) through the process 
automatically. To prove that this assumption was true for lower values of humidity as well, 
simulations were run at lower humidity values.  
Sim 
# 
Humidity 
Value Input Matrix 
Max LOD 
Time [min] 
Max LOD 
[%] 
End Time 
[min] 
End LOD 
[%] 
1 1 
[0 55 1 3200 900;100 75 1 3200 
0;120 NaN NaN NaN NaN] 100 6.75E+00 120 2.62E+00 
2 1 
[0 55 1 3200 900;100 75 1 3200 
0;122 NaN NaN NaN NaN] 100 6.75E+00 122 2.32E+00 
3 1 
[0 55 1 3200 900;100 75 1 3200 
0;124 NaN NaN NaN NaN] 100 6.75E+00 124 2.04E+00 
4 2 
[0 55 2 3200 900;100 75 2 3200 
0;120 NaN NaN NaN NaN] 100 7.03E+00 120 2.85E+00 
5 2 
[0 55 2 3200 900;100 75 2 3200 
0;122 NaN NaN NaN NaN] 100 7.03E+00 122 2.53E+00 
6 2 
[0 55 2 3200 900;100 75 2 3200 
0;124 NaN NaN NaN NaN] 100 7.03E+00 124 2.23E+00 
7 3 
[0 55 3 3200 900;100 75 3 3200 
0;120 NaN NaN NaN NaN] 100 7.31E+00 120 3.09E+00 
8 3 
[0 55 3 3200 900;100 75 3 3200 
0;122 NaN NaN NaN NaN] 100 7.31E+00 122 2.75E+00 
9 3 
[0 55 3 3200 900;100 75 3 3200 
0;124 NaN NaN NaN NaN] 100 7.31E+00 124 2.44E+00 
10 3 
[0 55 3 3200 900;100 75 3 3200 
0;126 NaN NaN NaN NaN] 100 7.31E+00 126 2.15E+00 
11 4 
[0 55 4 3200 900;100 75 4 3200 
0;120 NaN NaN NaN NaN] 100 7.60E+00 120 3.35E+00 
12 4 
[0 55 4 3200 900;100 75 4 3200 
0;122 NaN NaN NaN NaN] 100 7.60E+00 122 2.99E+00 
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13 4 
[0 55 4 3200 900;100 75 4 3200 
0;124 NaN NaN NaN NaN] 100 7.60E+00 124 2.66E+00 
14 4 
[0 55 4 3200 900;100 75 4 3200 
0;126 NaN NaN NaN NaN] 100 7.60E+00 126 2.35E+00 
15 4 
[0 55 4 3200 900;100 75 4 3200 
0;128 NaN NaN NaN NaN] 100 7.60E+00 128 2.07E+00 
16 5 
[0 55 5 3200 900;100 75 5 3200 
0;120 NaN NaN NaN NaN] 100 7.88E+00 120 3.63E+00 
17 5 
[0 55 5 3200 900;100 75 5 3200 
0;122 NaN NaN NaN NaN] 100 7.88E+00 122 3.25E+00 
18 5 
[0 55 5 3200 900;100 75 5 3200 
0;124 NaN NaN NaN NaN] 100 7.88E+00 124 2.90E+00 
19 5 
[0 55 5 3200 900;100 75 5 3200 
0;126 NaN NaN NaN NaN] 100 7.88E+00 126 2.58E+00 
20 5 
[0 55 5 3200 900;100 75 5 3200 
0;128 NaN NaN NaN NaN] 100 7.88E+00 128 2.28E+00 
21 5 
[0 55 5 3200 900;100 75 5 3200 
0;130 NaN NaN NaN NaN] 100 7.88E+00 130 2.01E+00 
22 7.6 
[0 55 7.6 3200 900;100 75 7.6 
3200 0;126 NaN NaN NaN NaN] 100 8.61E+00 126 3.23E+00 
23 7.6 
[0 55 7.6 3200 900;100 75 7.6 
3200 0;128 NaN NaN NaN NaN] 100 8.61E+00 128 2.89E+00 
24 7.6 
[0 55 7.6 3200 900;100 75 7.6 
3200 0;130 NaN NaN NaN NaN] 100 8.61E+00 130 2.57E+00 
25 7.6 
[0 55 7.6 3200 900;100 75 7.6 
3200 0;132 NaN NaN NaN NaN] 100 8.61E+00 132 2.28E+00 
26 7.6 
[0 55 7.6 3200 900;100 75 7.6 
3200 0;134 NaN NaN NaN NaN] 100 8.61E+00 134 2.01E+00 
 
As shown above, these were the simulations run at lower humidity values. It was proven 
that at lower humidity values, keeping all other inputs constant there did exists simulations 
that provided wanted LOD values. 
Based on all the data collected from the simulations, it was determined that the process 
could operate at any humidity value as long as the other inputs are optimized.  
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Section 26.5 Lyophilization Simulation Results 
 
 
Figure 26.5.1. As temperature increases, drying time decreases. As pressure increases, drying time decreases. 
Lower drying times are preferable.  
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Figure 26.5.2. As temperature increases, peak product temperature increases. As pressure increases, peak 
product temperature increases. Peak product temperatures above -21.0 ˚C do not satisfy product quality 
requirements.  
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Figure 26.5.3. The maximum sublimation rate is a function of the heat transfer properties of the vial. As 
temperature increases, maximum sublimation rate increases. At temperatures below -16˚C, maximum 
sublimation rate increases as pressure decreases. At temperatures above -16˚C, maximum sublimation rate 
increases as pressure increases. 
 
 
0.00E+00
2.00E-05
4.00E-05
6.00E-05
8.00E-05
1.00E-04
1.20E-04
1.40E-04
1.60E-04
-30 -25 -20 -15 -10 -5 0
M
ax
im
u
m
 S
u
b
li
m
at
io
n
 R
at
e 
(g
/s
)
Initial Chamber Temperature (C)
Maximum Sublimation Rate vs. Initial Chamber 
Temperature for 8R Vials
10 Pa 20 Pa 30 Pa 40 Pa
 174 
 
Figure 26.5.4. The lyophilization chamber can handle 50,000 vials at temperatures up to -26˚C, 40,000 vials at 
temperatures up to -17˚C, 30,000 vials at temperatures up to -6˚C, and only 20,000 vials at higher 
temperatures. This low batch size makes operation at 10 Pa economically unfavorable. 
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Figure 26.5.5. The lyophilization chamber can handle 60,000 vials at temperatures up to -15˚C, 50,000 vials at 
temperatures up to -10˚C, and 40,000 vials at higher temperatures.  
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Figure 26.5.6. The lyophilization chamber can handle 60,000 vials at temperatures up to -9˚C and 50,000 vials 
at higher temperatures. 
 
 
0
10000
20000
30000
40000
50000
60000
70000
-30 -25 -20 -15 -10 -5 0
N
u
m
b
er
 o
f 
V
ia
ls
Initial Chamber Temperature (C)
Number of 8R Vials vs. Initial Chamber Temperature at 
30 Pa
 177 
 
Figure 26.5.7. The lyophilization chamber can handle 60,000 vials at every simulated temperature. 
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Figure 26.5.8. As temperature increases, drying time decreases. As pressure increases, drying time decreases. 
Lower drying times are preferable. 
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Figure 26.5.9. As temperature increases, peak product temperature increases. As pressure increases, peak 
product temperature increases. All simulations satisfied peak product temperature constraints.  
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Figure 26.5.10. As temperature increases, maximum sublimation rate increases. As pressure increases, 
maximum sublimation rate decreases. 
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Figure 26.5.11. The lyophilization chamber can handle 20,000 vials at temperatures up to -15˚C and only 
10,000 vials at higher temperatures. This low batch size makes operation at 10 Pa economically unfavorable. 
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Figure 26.5.12. The lyophilization chamber can handle 50,000 vials at temperatures up to -25˚C, 40,000 vials 
up to -20˚C, 30,000 vials up to -9˚C and only 20,000 vials at higher temperatures. 
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Figure 26.5.13. The lyophilization chamber can handle 60,000 vials at temperatures up to -20˚C, 50,000 vials 
up to -15˚C, 40,000 vials up to -8˚C and only 30,000 vials at higher temperatures. 
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Figure 26.5.14. The lyophilization chamber can handle 60,000 vials at temperatures up to -14˚C, 50,000 vials 
up to -8˚C and only 40,000 vials at higher temperatures. 
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Section 26.6 Economic Cost Summaries 
Fluid Bed Granulation Base Case – Power Usage 
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Figures 26.6.1-5 – Detailed economic summaries of how power functions were calculated for the base case. In 
descending order, figures correspond to condenser, heat exchanger, fan, heater, and pump power usage 
 
Fluid Bed Granulation Recommended Case 
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Figures 26.6.6-10 – Detailed economic summaries of how power functions were calculated for the 
recommended case. In descending order, figures correspond to condenser, heat exchanger, fan, heater, and 
pump power usage 
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Lyophilization Base Case – Vacuum Pump Power Usage 
*Power usage for the other pieces of equipment were calculated externally using Matlab 
and manually input into the model 
 
Figures 26.6.11 – Detailed economic summary of how power functions were calculated for the base case (26 
Pa). Displayed is the calculated power for the vacuum pump as a function of operating pressure. Other power 
functions were calculated manually. 
 
Lyophilization Recommended Case (8R) – Vacuum Pump Power Usage 
 
Figures 26.6.12 – Detailed economic summary of how power functions were calculated for the recommended 
case (30 Pa). Displayed is the calculated power for the vacuum pump as a function of operating pressure. 
Other power functions were calculated manually. 
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Lyophilization Base Case (20ml) – Vacuum Pump Power Usage 
 
Figures 26.6.13 – Detailed economic summary of how power functions were calculated for the recommended 
case (30 Pa). Displayed is the calculated power for the vacuum pump as a function of operating pressure. 
Other power functions were calculated manually. 
 
Section 26.7 Financial Summary of NPV Analysis 
Fluid Bed Granulation 
Table 26.7.1 – Base case cashflow summary for NPV analysis over 15 year life. Sales and non-operational costs 
were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was 
applied. 
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Table 26.7.2 – Recommended case cashflow summary for NPV analysis over 15 year life. Recommended case 
corresponds to 28.3% annual operational cost savings. Sales and non-operational costs were assumed constant 
for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was applied. 
 
Table 26.7.3 – 10% savings case cash flow summary for NPV analysis over 15 year life. Sales and non-operational 
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% 
was applied. 
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Table 26.7.4 – 35% savings case cash flow summary for NPV analysis over 15 year life. Sales and non-operational 
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% 
was applied. 
 
Lyophilization 
Table 26.7.5 – Base case cashflow summary for NPV analysis over 15 year life. Sales and non-operational costs 
were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was 
applied. 
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Table 26.7.6 – Recommended case cashflow summary for NPV analysis over 15 year life. Recommended case 
corresponds to 16.4% annual operational cost savings. Sales and non-operational costs were assumed constant 
for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% was applied. 
 
 
Table 26.7.7 – 7.5% savings case cashflow summary for NPV analysis over 15 year life. Sales and non-operational 
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% 
was applied. 
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Table 26.7.7 – 30% savings case cashflow summary for NPV analysis over 15 year life. Sales and non-operational 
costs were assumed constant for years after 2018. A 20-year MACRS schedule was used and a tax rate of 23% 
was applied. 
 
 
